{"content":"<li class=\"n-box-item date-title\" data-end=\"1515041999\" data-start=\"1514955600\" data-txt=\"Monday, December 23, 2019\">Wednesday, January  3, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3321072\" data-ts=\"1515027130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNTA\" target=\"_blank\">MNTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321072-momentaplus-6-m710-patient-trial-set-for-first-half\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Momenta +6% with M710 patient trial set for first half</a></h4><ul>   <li>Shares in Momenta Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MNTA' title='Momenta Pharmaceuticals, Inc.'>MNTA</a>) have <font color='green'>risen 6%</font> after hours following news that it and Mylan have set a development strategy for its Eylea biosimilar M710 that sets a <a href=\"https://seekingalpha.com/pr/17037289-momenta-mylan-announce-development-strategy-m710-proposed-biosimilar-eylea-aflibercept\" target=\"_blank\">patient trial in the first half of this year</a>.</li>    <li>\"This trial is a randomized, double-blind, active-control, multi-center study in patients with diabetic macular edema to compare the safety, efficacy and immunogenicity of M710 with EYLEA,\" the companies say.</li>    <li>Eylea is the market-leading vascular endothelial growth factor inhibitor indicated for treatment of neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema and diabetic retinopathy in patients with diabetic macular edema.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321072\" data-linked=\"Momenta +6% with M710 patient trial set for first half\" data-tweet=\"$MNTA - Momenta +6% with M710 patient trial set for first half https://seekingalpha.com/news/3321072-momentaplus-6-m710-patient-trial-set-for-first-half?source=tweet\" data-url=\"https://seekingalpha.com/news/3321072-momentaplus-6-m710-patient-trial-set-for-first-half\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321067\" data-ts=\"1515023581\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFUN\" target=\"_blank\">SFUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321067-fang-holdingsminus-2_3-15_5m-shares-on-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fang Holdings -2.3% with 15.5M shares on offer</a></h4><ul>   <li>Fang Holdings (NYSE:<a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Ltd. ADS'>SFUN</a>) has <font color='red'>slipped 2.3%</font> after hours as Bloomberg reports a block of 15.5M shares is set to be offered.</li>    <li>Those shares will be put up by Morgan Stanley at $4.90-$5.10 each, a 1.4%-5.2% discount; the company's ADS closed at $5.17 today and are quoting at $5.05 postmarket.</li>    <li>The seller is unknown, but Bloomberg notes five holders with at least that many shares: General Atlantic, Next Decade, Davis Selected Advisers, Fosun International, and HSBC.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321067\" data-linked=\"Fang Holdings -2.3% with 15.5M shares on offer\" data-tweet=\"$SFUN - Fang Holdings -2.3% with 15.5M shares on offer https://seekingalpha.com/news/3321067-fang-holdingsminus-2_3-15_5m-shares-on-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3321067-fang-holdingsminus-2_3-15_5m-shares-on-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321058\" data-ts=\"1515019459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAND\" target=\"_blank\">SAND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321058-sandstorm-gold-reports-record-gold-equivalent-output-in-2017\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sandstorm Gold reports record gold equivalent output in 2017</a></h4><ul>     <li>Sandstorm Gold (NYSEMKT:<a href='https://seekingalpha.com/symbol/SAND' title='Sandstorm Gold Ltd.'>SAND</a>) <font color='green'>+5.4%</font> after-hours on news it tallied <a href=\"https://seekingalpha.com/pr/17037382-sandstorm-gold-announces-record-production-completes-sale-us-18-million-equinox-securities\" target=\"_blank\">record gold equivalent production</a> last year, and reports the sale of US$18M of securities of Equinox Gold.</li>     <li>SAND says it sold 54,600 attributable gold equivalent oz. in 2017, the highest total in its history and nearly 10% greater than 49,731 oz. in 2016.</li>     <li>SAND says production was generated from 20 streams and royalties, with ~80% from operations run by major and mid-tier mining companies.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321058\" data-linked=\"Sandstorm Gold reports record gold equivalent output in 2017\" data-tweet=\"$SAND - Sandstorm Gold reports record gold equivalent output in 2017 https://seekingalpha.com/news/3321058-sandstorm-gold-reports-record-gold-equivalent-output-in-2017?source=tweet\" data-url=\"https://seekingalpha.com/news/3321058-sandstorm-gold-reports-record-gold-equivalent-output-in-2017\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321055\" data-ts=\"1515019036\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321055-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/ZUMZ' title='Zumiez Inc.'>ZUMZ</a> <font color='green'>+13.1%</font>. <a href='https://seekingalpha.com/symbol/MNTA' title='Momenta Pharmaceuticals, Inc.'>MNTA</a> <font color='green'>+6.0%</font>. <a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a> <font color='green'>+5.0%</font>. <a href='https://seekingalpha.com/symbol/FND' title='Floor & Decor Holdings, Inc.'>FND</a> <font color='green'>+2.0%</font>. <a href='https://seekingalpha.com/symbol/NMFC' title='New Mountain Finance'>NMFC</a> <font color='green'>+1.8%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a> <font color='red'>-7.1%</font>. <a href='https://seekingalpha.com/symbol/CLMT' title='Calumet Specialty Products Partners, L.P.'>CLMT</a> <font color='red'>-6.7%</font>. <a href='https://seekingalpha.com/symbol/PAA' title='Plains All American Pipeline, L.P.'>PAA</a> <font color='red'>-4.4%</font>. <a href='https://seekingalpha.com/symbol/BPL' title='Buckeye Partners L.P.'>BPL</a> <font color='red'>-4.4%</font>. <a href='https://seekingalpha.com/symbol/ENLK' title='EnLink Midstream Partners, LP'>ENLK</a> <font color='red'>-3.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321055\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$ZUMZ $MNTA $DCIX - After Hours Gainers / Losers https://seekingalpha.com/news/3321055-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3321055-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321048\" data-ts=\"1515016708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321048-amd-processor-exploit-is-near-zero-risk-to-chips\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD: Processor exploit is &#39;near-zero&#39; risk to its chips</a></h4><ul>   <li>Now <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> is picking up a bit in after-hours trading, <font color='green'>up 1%</font>, after it's issued a statement breaking with Intel's (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) take on today's processor-flaw issue and says the <a href=\"https://www.cnbc.com/2018/01/03/amd-rebukes-intel-says-flaw-poses-near-zero-risk-to-its-chips.html\" target=\"_blank\">exploit poses a \"near-zero risk\"</a> to its own chips.</li>    <li>The company says it will publish security research on the flaw later today, but differs with Intel's take that the flaw might be widespread and affect various companies.</li>    <li>\"To be clear, the security research team identified three variants targeting speculative execution,\" AMD says. \"The threat and the response to the three variants differ by microprocessor company, and AMD is not susceptible to all three variants. Due to differences in AMD's architecture, we believe there is a near zero risk to AMD processors at this time.\"</li><li>Intel's now <font color='red'>down 1.1%</font> after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321030-arm-holdings-working-intel-amd-processor-exploit-issue\" target=\"_blank\">ARM Holdings working with Intel, AMD on processor exploit issue</a> (Jan. 03 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321016-intel-responds-security-flaw-report-intc-trims-losses-amd-cuts-gains-updated\" target=\"_blank\">Intel responds to security flaw report; INTC trims losses, AMD cuts gains (updated)</a> (Jan. 03 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320844-amd-plus-6_7-percent-intel-chip-flaw-report\" target=\"_blank\">AMD +6.7% on Intel chip flaw report</a> (Jan. 03 2018)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3321048\" data-linked=\"AMD: Processor exploit is &#39;near-zero&#39; risk to its chips\" data-tweet=\"$AMD $AMD $INTC - AMD: Processor exploit is &#39;near-zero&#39; risk to its chips https://seekingalpha.com/news/3321048-amd-processor-exploit-is-near-zero-risk-to-chips?source=tweet\" data-url=\"https://seekingalpha.com/news/3321048-amd-processor-exploit-is-near-zero-risk-to-chips\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>313&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321047\" data-ts=\"1515016325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAD\" target=\"_blank\">RAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321047-rite-aid-fiscal-q3-top-line-down-6-non-gaap-eps-down-100-cash-flow-down-41-shares-down-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rite Aid fiscal Q3 top line down 6%, non-GAAP EPS down 100%, cash flow down 41%; shares down 5% after hours on revenue miss</a></h4><ul><li>Rite Aid (NYSE:<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>) fiscal<a href=\"https://www.sec.gov/Archives/edgar/data/84129/000114420418000525/tv482415_ex99-1.htm\" target=\"_blank\"> Q3 results</a> ($M): Revenues: 5,353.2 (-5.6%); Retail Pharmacy: 3,959.0 (-3.0%); Pharmacy Services: 1,445.1 (-12.2%).</li><li>Net Income: 81.0 (+440.0%); non-GAAP Net Income: 1,619.0 (-94.0%); EPS: 0.08 (+700.0%); non-GAAP EPS: 0.00 (-100.0%).</li><li>Cash flow ops: 129.0 (-41.0%).</li><li>1,932 stores and three distribution centers are in the process of being sold to Walgreens Boots Alliance.</li><li>Consensus view was a loss/share of ($0.02) on revenues of $7.45B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321047\" data-linked=\"Rite Aid fiscal Q3 top line down 6%, non-GAAP EPS down 100%, cash flow down 41%; shares down 5% after hours on revenue miss\" data-tweet=\"$RAD - Rite Aid fiscal Q3 top line down 6%, non-GAAP EPS down 100%, cash flow down 41%; shares down 5% after hours on revenue miss https://seekingalpha.com/news/3321047-rite-aid-fiscal-q3-top-line-down-6-non-gaap-eps-down-100-cash-flow-down-41-shares-down-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3321047-rite-aid-fiscal-q3-top-line-down-6-non-gaap-eps-down-100-cash-flow-down-41-shares-down-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321031\" data-ts=\"1515014590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APHB\" target=\"_blank\">APHB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321031-ampliphis-bacteriophage-candidates-show-significant-treatment-benefits-in-expanded-access\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AmpliPhi&#39;s bacteriophage candidates show significant treatment benefits in expanded access study; shares up 30% after hours</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17037288-ampliphi-biosciences-announces-positive-interim-results-single-patient-expanded-access\" target=\"_blank\">Topline data</a> from a single-patient expanded access program involving severely ill antibiotic-resistant patients showed treatment with AmpliPhi Biosciences' (NYSEMKT:<a href='https://seekingalpha.com/symbol/APHB' title='AmpliPhi Biosciences Corp.'>APHB</a>) bacteriophage therapeutics could resolve the infections.</li><li>Specifically, six of seven patients (86%) achieved treatment success as defined by complete resolution of the infection or significant improvement of baseline symptoms and signs. Four patients with <em>Staphylococcus aureus </em>infections received intravenous <a href=\"http://www.ampliphibio.com/pipeline/ab-sa01/\" target=\"_blank\">AB-SA01</a> while three with <em>Pseudomonas aeruginosa</em> infections received intravenous or inhaled <a href=\"http://www.ampliphibio.com/pipeline/ab-pa01/\" target=\"_blank\">AB-PA01</a>. There was one death determined to be unrelated to bacteriophage treatment.</li><li>Both candidates were well-tolerated with no serious treatment-related adverse events reported.</li><li>Up to another 20 patients will be treated in H1 2018. The company intends to discuss the data with the FDA to determine a path to registration.</li><li>Management will host a conference call at 4:30 pm ET to discuss the results.</li><li>Shares are up&nbsp;<font color='green'>30%</font>&nbsp;after hours on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321031\" data-linked=\"AmpliPhi&#39;s bacteriophage candidates show significant treatment benefits in expanded access study; shares up 30% after hours\" data-tweet=\"$APHB $ARMP - AmpliPhi&#39;s bacteriophage candidates show significant treatment benefits in expanded access study; shares up 30% after hours https://seekingalpha.com/news/3321031-ampliphis-bacteriophage-candidates-show-significant-treatment-benefits-in-expanded-access?source=tweet\" data-url=\"https://seekingalpha.com/news/3321031-ampliphis-bacteriophage-candidates-show-significant-treatment-benefits-in-expanded-access\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321030\" data-ts=\"1515014429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFTBY\" target=\"_blank\">SFTBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321030-arm-holdings-working-intel-amd-on-processor-exploit-issue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ARM Holdings working with Intel, AMD on processor exploit issue</a></h4><ul>   <li>ARM Holdings (<a href='https://seekingalpha.com/symbol/SFTBY' title='SoftBank Group ADR'>OTCPK:SFTBY</a>) says it's <a href=\"https://www.reuters.com/article/brief-arm-says-working-with-intel-amd-on/brief-arm-says-working-with-intel-amd-on-mitigation-for-new-method-to-exploit-certain-high-end-processors-idUSFWN1OY0LD\" target=\"_blank\">working with Intel</a> (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) and <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> on mitigation of the exploits reported for certain high-end chips, according to Reuters.</li>    <li>The exploits -- which sent Intel stock tumbling today and AMD to strong gains -- are not an \"architectural flaw,\" ARM says.</li>    <li>At worst, the exploit method could result in \"small pieces of data being accessed from privileged memory,\" it says.</li>    <li>Intel <a href=\"https://seekingalpha.com/news/3321016-intel-responds-security-flaw-report-intc-trims-losses-amd-cuts-gains\" target=\"_blank\">issued its response to the reports</a> in the hour before the market closing, mitigating its price decline; <a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> finished the day <font color='red'>down a relatively low 3.4%</font> and is <font color='red'>down 0.2%</font> after hours, while <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> trimmed gains to finish <font color='green'>up 5.2%</font> (and is <font color='red'>down 0.7%</font> after hours).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321030\" data-linked=\"ARM Holdings working with Intel, AMD on processor exploit issue\" data-tweet=\"$SFTBY $SFTBY $INTC - ARM Holdings working with Intel, AMD on processor exploit issue https://seekingalpha.com/news/3321030-arm-holdings-working-intel-amd-on-processor-exploit-issue?source=tweet\" data-url=\"https://seekingalpha.com/news/3321030-arm-holdings-working-intel-amd-on-processor-exploit-issue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321020\" data-ts=\"1515012459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPD\" target=\"_blank\">EPD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321020-enterprise-products-to-expand-orla-nat-gas-processing-complex\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enterprise Products to expand Orla nat gas processing complex</a></h4><ul>     <li>Enterprise Products Partners (<a href='https://seekingalpha.com/symbol/EPD' title='Enterprise Products Partners L.P'>EPD</a> <font color='green'>+2.8%</font>) approves a project <a href=\"https://seekingalpha.com/pr/17036524-enterprise-products-expand-orla-natural-gas-processing-complex-west-texas\" target=\"_blank\">adding 300M cf/day of capacity</a> at its Orla cryogenic natural gas processing plant under construction in Texas.</li>     <li>EPD says the addition of the third processing train at Orla will increase inlet volume capacity to 900M cf/day and it to expand natural gas liquids extraction capabilities by 40K bbl/day to 120K.</li>     <li>EPD expects the third train to begin service during Q2 2019; Orla trains one and two remain on schedule for completion in Q2 and Q3 2018, respectively.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321020\" data-linked=\"Enterprise Products to expand Orla nat gas processing complex\" data-tweet=\"$EPD - Enterprise Products to expand Orla nat gas processing complex https://seekingalpha.com/news/3321020-enterprise-products-to-expand-orla-nat-gas-processing-complex?source=tweet\" data-url=\"https://seekingalpha.com/news/3321020-enterprise-products-to-expand-orla-nat-gas-processing-complex\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321019\" data-ts=\"1515011791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIOT\" target=\"_blank\">RIOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321019-riot-blockchain-lower-after-ceo-cashes-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Riot Blockchain lower after CEO cashes in</a></h4><ul><li>Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) CEO John O'Rourke <a href=\"https://seekingalpha.com/filing/3815250\" target=\"_blank\">sold more than 30K shares </a>on Friday. The sale brought in about $869K, or $700K more than it would have a couple of months earlier (when Riot was a biotech stock called Bioptix).</li><li>O'Rourke continues to hold 52K shares in RIOT.</li><li>Shares were&nbsp;<font color='red'>down about 2%</font>&nbsp;yesterday and&nbsp;<font color='red'>another 13.6%</font>&nbsp;today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321019\" data-linked=\"Riot Blockchain lower after CEO cashes in\" data-tweet=\"$RIOT - Riot Blockchain lower after CEO cashes in https://seekingalpha.com/news/3321019-riot-blockchain-lower-after-ceo-cashes-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3321019-riot-blockchain-lower-after-ceo-cashes-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321013\" data-ts=\"1515009991\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERJ\" target=\"_blank\">ERJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321013-bloomberg-boeing-seeking-control-of-embraer-defense-safeguards\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Boeing seeking control of Embraer with defense safeguards</a></h4><ul>     <li>Embraer (<a href='https://seekingalpha.com/symbol/ERJ' title='Embraer S.A.'>ERJ</a> <font color='green'>+3.5%</font>) pushes ahead to 52-week highs as Bloomberg reports Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='red'>-0.1%</font>) may seek control of the Brazilian company as <a href=\"https://www.bloomberg.com/news/articles/2018-01-03/boeing-is-said-to-seek-embraer-control-with-defense-protections\" target=\"_blank\">part of a deal that would include safeguards</a> for the interests of the country's defense ministry.</li>     <li>BA is arguing that agreements it has made in Australia and the U.K. show it can operate defense businesses without compromising military plans, and the Brazilian government, which has the power to block an acquisition, has suggested it has some flexibility on the issue of control, according to the report.</li>     <li>The companies also are said to be seeking an agreement with the government soon, considering the risk of mounting political opposition ahead of Brazil&rsquo;s presidential election in H2 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321013\" data-linked=\"Bloomberg: Boeing seeking control of Embraer with defense safeguards\" data-tweet=\"$ERJ $ERJ $BA - Bloomberg: Boeing seeking control of Embraer with defense safeguards https://seekingalpha.com/news/3321013-bloomberg-boeing-seeking-control-of-embraer-defense-safeguards?source=tweet\" data-url=\"https://seekingalpha.com/news/3321013-bloomberg-boeing-seeking-control-of-embraer-defense-safeguards\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321010\" data-ts=\"1515009350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321010-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CPAH' title='CounterPath Corporation'>CPAH</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/BB' title='BlackBerry Ltd.'>BB</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/RDFN' title='Redfin'>RDFN</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321010\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$RENN $TEUM $LEDS - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3321010-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3321010-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321006\" data-ts=\"1515007992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BJRI\" target=\"_blank\">BJRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321006-rally-time-for-bjs-restaurants-after-stifel-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rally time for BJ&#39;s Restaurants after Stifel upgrade</a></h4><ul><li>BJ's Restaurants (<a href='https://seekingalpha.com/symbol/BJRI' title='BJ&#39;s Restaurants, Inc.'>BJRI</a> <font color='green'>+7.9%</font>) rallies nicely after Stifel Nicolaus upgrades the restaurant name to Buy from Hold after taking its estimate for 2018 EPS higher.</li><li>Expected to work in BJ's favor this year is an improved economic backdrop, new menu additions and the potential for higher pricing.</li><li>Stifel's new price target on BJ's is $44.</li><li>Sources: CNBC and Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3321006\" data-linked=\"Rally time for BJ&#39;s Restaurants after Stifel upgrade\" data-tweet=\"$BJRI - Rally time for BJ&#39;s Restaurants after Stifel upgrade https://seekingalpha.com/news/3321006-rally-time-for-bjs-restaurants-after-stifel-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3321006-rally-time-for-bjs-restaurants-after-stifel-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321005\" data-ts=\"1515007857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321005-reuters-google-looking-to-exit-zagat-review-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Google looking to exit Zagat review business</a></h4><ul>   <li>Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+1.9%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='green'>+2%</font>) is exploring a <a href=\"https://www.reuters.com/article/us-aptiv-lyft/aptiv-lyft-discuss-engagement-beyond-self-driving-ride-partnership-idUSKBN1ER1NV?il=0\" target=\"_blank\">sale of the Zagat restaurant-review business</a>, Reuters reports.</li>    <li>The search giant had bought Zagat in 2011 for $151M with ambitious plans spearheaded by then-exec Marissa Mayer, but those plans changed as Google focused on its Google+ social networking efforts.</li>    <li>It's currently integrating the reviews into its Maps product, which has gotten a heavy recent focus on location reviews and user-generated content.</li>    <li>Any deal would be likely to include the brand name and Zagat website, sources told the news service.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321005\" data-linked=\"Reuters: Google looking to exit Zagat review business\" data-tweet=\"$GOOG $GOOG $GOOGL - Reuters: Google looking to exit Zagat review business https://seekingalpha.com/news/3321005-reuters-google-looking-to-exit-zagat-review-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3321005-reuters-google-looking-to-exit-zagat-review-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321004\" data-ts=\"1515007694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPOR\" target=\"_blank\">GPOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321004-gulfport-energy-nabs-noble-energy-exec-moore-to-fill-coo-slot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gulfport Energy nabs Noble Energy exec Moore to fill COO slot</a></h4><ul>     <li>Gulfport Energy (<a href='https://seekingalpha.com/symbol/GPOR' title='Gulfport Energy Corporation'>GPOR</a> <font color='green'>+1.7%</font>) is higher after naming Donnie Moore, Noble Energy's (<a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a> <font color='green'>+3.2%</font>) head of Texas operations in the Eagle Ford and Delaware Basin, as its <a href=\"https://seekingalpha.com/pr/17036106-gulfport-energy-corporation-names-donnie-moore-chief-operating-officer\" target=\"_blank\">next COO</a>, effective Jan. 8.</li>     <li>Moore joined NBL in 2007, and formerly was VP of the company's Marcellus unit and manager of operations for the Wattenberg/DJ Basin unit; he previously held roles with ARCO Oil and Gas, Vastar Resources and BP America as part of his 28 years of operations and subsurface leadership experience.</li>     <li>Moore's pay package at NBL was not publicly disclosed since he was not one of the company's five highest-paid employees, but his <a href=\"https://www.epmag.com/gulfport-energy-taps-former-noble-vp-donnie-moore-coo-1676456\" target=\"_blank\">new compensation plan</a> exceeds some of his former NBL peers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321004\" data-linked=\"Gulfport Energy nabs Noble Energy exec Moore to fill COO slot\" data-tweet=\"$GPOR $GPOR $NBL - Gulfport Energy nabs Noble Energy exec Moore to fill COO slot https://seekingalpha.com/news/3321004-gulfport-energy-nabs-noble-energy-exec-moore-to-fill-coo-slot?source=tweet\" data-url=\"https://seekingalpha.com/news/3321004-gulfport-energy-nabs-noble-energy-exec-moore-to-fill-coo-slot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321003\" data-ts=\"1515007557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZNGA\" target=\"_blank\">ZNGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321003-zyngaplus-2_7-after-new-overweight-rating-from-consumer-edge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zynga +2.7% after new Overweight rating from Consumer Edge</a></h4><ul>   <li>Zynga (NASDAQ:<a href='https://seekingalpha.com/symbol/ZNGA' title='Zynga'>ZNGA</a>) has <font color='green'>gained 2.7%</font> after getting initiated at Overweight by Consumer Edge.</li>    <li>The firm joins other bulls including Wedbush, Cowen, Benchmark and Piper Jaffray.</li>    <li>It's set a $4.50 price target, implying 12% upside from current pricing.</li>    <li>Analyst consensus on Zynga is nearly evenly balanced between Buy and Hold ratings, with no Sells on the Street.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321003\" data-linked=\"Zynga +2.7% after new Overweight rating from Consumer Edge\" data-tweet=\"$ZNGA - Zynga +2.7% after new Overweight rating from Consumer Edge https://seekingalpha.com/news/3321003-zyngaplus-2_7-after-new-overweight-rating-from-consumer-edge?source=tweet\" data-url=\"https://seekingalpha.com/news/3321003-zyngaplus-2_7-after-new-overweight-rating-from-consumer-edge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320998\" data-ts=\"1515006869\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320998-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/REXX' title='Rex Energy Corporation'>REXX</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/GST' title='Gastar Exploration Inc.'>GST</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TGB' title='Taseko Mines Limited'>TGB</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/MUX' title='McEwen Mining Inc.'>MUX</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320998\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$REXX $HOS $KEG - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3320998-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3320998-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320997\" data-ts=\"1515006701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPB\" target=\"_blank\">SPB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320997-spectrum-brands-rallies-after-strategy-reset\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spectrum Brands rallies after strategy reset</a></h4><ul><li>Wall Street analysts approve of the plan by Spectrum Brands (NYSE:<a href='https://seekingalpha.com/symbol/SPB' title='Spectrum Brands, Inc.'>SPB</a>) to sell off two of its lower-margin businesses.</li><li>Wells Fargo estimates the sales could generate as much as $2B to $2.5B in what it sees as a smart strategy,&nbsp;while KeyBanc thinks the deals will help Spectrum focus on its core businesses.</li><li>Source: Bloomberg</li><li>Shares of Spectrum Brands are&nbsp;<font color='green'>up 8.80%</font>&nbsp;on the day.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320854-spectrum-brands-explore-strategic-options-two-business-lines\" target=\"_blank\">Spectrum Brands to explore strategic options for two business lines</a> (Jan. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3320997\" data-linked=\"Spectrum Brands rallies after strategy reset\" data-tweet=\"$SPB - Spectrum Brands rallies after strategy reset https://seekingalpha.com/news/3320997-spectrum-brands-rallies-after-strategy-reset?source=tweet\" data-url=\"https://seekingalpha.com/news/3320997-spectrum-brands-rallies-after-strategy-reset\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320995\" data-ts=\"1515005839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARWR\" target=\"_blank\">ARWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320995-arrowhead-rides-amgen-rally-shares-up-26\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arrowhead rides Amgen rally, shares up 26%</a></h4><ul><li>Arrowhead Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a> <font color='green'>+26.1%</font>) is up on more than a 4x surge in volume. The catalyst appears to be bullish action from Amgen (<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color='green'>+2.3%</font>), albeit absent high volume.</li><li>In a slide listing its cardiovascular programs within a corporate presentation, Amgen includes preclinical-stage AMG 890, an RNAi candidate for atherosclerosis that it licensed from Arrowhead in 2016. It also <a href=\"http://wwwext.amgen.com/media/news-releases/2016/09/amgen-and-arrowhead-pharmaceuticals-announce-two-cardiovascular-collaborations/\" target=\"_blank\">purchased</a> $21.5M in Arrowhead stock at the time.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3211499-arrowhead-pharma-inks-two-agreements-amgen-rnai-candidates-cardiovascular-disease-shares-21\" target=\"_blank\">Arrowhead Pharma inks two agreements with Amgen for RNAi candidates in cardiovascular disease; shares up 21% premarket</a> (Sept. 29, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3320995\" data-linked=\"Arrowhead rides Amgen rally, shares up 26%\" data-tweet=\"$ARWR $ARWR $AMGN - Arrowhead rides Amgen rally, shares up 26% https://seekingalpha.com/news/3320995-arrowhead-rides-amgen-rally-shares-up-26?source=tweet\" data-url=\"https://seekingalpha.com/news/3320995-arrowhead-rides-amgen-rally-shares-up-26\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320994\" data-ts=\"1515005483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RL\" target=\"_blank\">RL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320994-cascend-secuities-warns-on-ralph-lauren\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cascend Secuities warns on Ralph Lauren</a></h4><ul>     <li>Ralph Lauren (<a href='https://seekingalpha.com/symbol/RL' title='Ralph Lauren Corporation'>RL</a> <font color='red'>-3%</font>) slides after Cascend Securities warns that the retailer's holiday sales were weak, including a 10% decline in demand for products in December.</li>     <li>Cascend <a href=\"https://www.cascend.com/rl-demand-measurements-show-15-y-y-december-january-3-2017/\" target=\"_blank\">update</a>: \"We&rsquo;ve been negative on RL because our consumer demand data shows decelerating Y/Y trends for RL. Reiterate SELL.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320994\" data-linked=\"Cascend Secuities warns on Ralph Lauren\" data-tweet=\"$RL - Cascend Secuities warns on Ralph Lauren https://seekingalpha.com/news/3320994-cascend-secuities-warns-on-ralph-lauren?source=tweet\" data-url=\"https://seekingalpha.com/news/3320994-cascend-secuities-warns-on-ralph-lauren\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320993\" data-ts=\"1515004896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANGI\" target=\"_blank\">ANGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320993-angiplus-6_7-mkm-sees-huge-internet-opportunity-for-home-services\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ANGI +6.7% as MKM sees huge Internet opportunity for home services</a></h4><ul>   <li>ANGI Homeservices (NASDAQ:<a href='https://seekingalpha.com/symbol/ANGI' title='ANGI Homeservices Inc.'>ANGI</a>) is <font color='green'>up 6.7%</font> today after MKM upgraded the stock and said the $5.5B company \"could be worth $13B-$16B by 2022.\"</li>    <li>That's if it delivers on the promise of last fall's merger of Angie's List with IAC's HomeAdvisor (<a href='https://seekingalpha.com/symbol/IAC' title='IAC/InterActiveCorp'>IAC</a> <font color='green'>+2.5%</font>), says analyst Rob Sanderson, who boosted ANGI shares to Buy and gave them a Street-high price target of $15 (implying 23% upside from today's already higher price).</li>    <li>Its sector is \"one of the largest opportunities still relatively untouched by Internet platforms,\" Sanderson says, adding that an \"Internet marketplace in this category is inevitable given secular trends in technology and consumer behavior.\" (h/t Bloomberg)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320993\" data-linked=\"ANGI +6.7% as MKM sees huge Internet opportunity for home services\" data-tweet=\"$ANGI $ANGI $IAC - ANGI +6.7% as MKM sees huge Internet opportunity for home services https://seekingalpha.com/news/3320993-angiplus-6_7-mkm-sees-huge-internet-opportunity-for-home-services?source=tweet\" data-url=\"https://seekingalpha.com/news/3320993-angiplus-6_7-mkm-sees-huge-internet-opportunity-for-home-services\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320992\" data-ts=\"1515004477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAMP\" target=\"_blank\">CAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320992-calamp-trimble-partnering-on-field-service-management\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CalAmp, Trimble partnering on field service management</a></h4><ul>   <li>CalAmp (<a href=\"http://seekingalpha.com/symbol/CAMP\" target=\"_blank\">CAMP</a> <font color='green'>+1.7%</font>) and Trimble Navigation (<a href=\"http://seekingalpha.com/symbol/TRMB\" target=\"_blank\">TRMB</a> <font color='green'>+1.8%</font>) are coming together on a <a href=\"https://seekingalpha.com/pr/17036377-trimble-partners-calamp-deliver-fleet-asset-management-solutions\" target=\"_blank\">partnership</a> to offer customized tracking for fleet and asset management solutions.</li>    <li>That will mean custom telematics through CalAmp devices with Trimble focused on value-added fleet management, work management, diagnostics, driver safety and mobility software and cloud services.</li>    <li>The solution will track locations of vehicles and assets as well as incorporate warnings and diagnostic information to allow better service technician deployment.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320992\" data-linked=\"CalAmp, Trimble partnering on field service management\" data-tweet=\"$CAMP $CAMP $TRMB - CalAmp, Trimble partnering on field service management https://seekingalpha.com/news/3320992-calamp-trimble-partnering-on-field-service-management?source=tweet\" data-url=\"https://seekingalpha.com/news/3320992-calamp-trimble-partnering-on-field-service-management\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320991\" data-ts=\"1515004155\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACB\" target=\"_blank\">ACB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320991-citron-bearish-on-aurora-cannabis-sees-almost-40-downside-risk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron bearish on Aurora Cannabis, sees almost 40% downside risk</a></h4><ul><li>Short seller Citron Research takes a <a href=\"https://twitter.com/CitronResearch/status/948609862094569472\" target=\"_blank\">negative view </a>on Canadian medical pot producer Aurora Cannabis (ACBFF <font color='green'>+15.2%</font>) with a short-term price target of $6.50 (39% downside risk).</li><li>Citron cites the lack of a clear path to profitability, the absence of intellectual property, self-dealing and insider sales by executives and Enron-esque mark-to-market accounting on biological assets.</li><li>Shares have run up over four-fold since early November.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320991\" data-linked=\"Citron bearish on Aurora Cannabis, sees almost 40% downside risk\" data-tweet=\"$ACB - Citron bearish on Aurora Cannabis, sees almost 40% downside risk https://seekingalpha.com/news/3320991-citron-bearish-on-aurora-cannabis-sees-almost-40-downside-risk?source=tweet\" data-url=\"https://seekingalpha.com/news/3320991-citron-bearish-on-aurora-cannabis-sees-almost-40-downside-risk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>101&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320988\" data-ts=\"1515003342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320988-benchmark-wdc-nvda-adding-fuel-to-risc-v-movement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Benchmark: WDC, NVDA adding fuel to RISC-V movement</a></h4><ul>    <li>A new innovation in computer chip architecture is taking hold, Benchmark notes, and it could be <a href=\"https://www.barrons.com/articles/western-dig-nvidia-on-board-with-risc-v-so-pay-attention-says-benchmark-1515001875?mod=hp_RTA&amp;&amp;mg=prod/accounts-barrons\" target=\"_blank\">\"disruptive\" for traditional processors</a> (and a possible boon to companies getting on board).</li>    <li>RISC-V is the latest version of the \"reduced instruction set\" architecture, a more modifiable system allowing for more customer tailoring of silicon, and a note from Benchmark's Gary Mobley highlights what's going on in the area.</li>    <li>Western Digital (<a href=\"http://seekingalpha.com/symbol/WDC\" target=\"_blank\">WDC</a> <font color='green'>+1%</font>) has \"pledged to transition its own consumption of processors to RISC-V,\" Mobley notes, and Nvidia (<a href=\"http://seekingalpha.com/symbol/NVDA\" target=\"_blank\">NVDA</a> <font color='green'>+5.7%</font>) quietly noted it will build its next-gen GPU microcontroller on the new instruction set.</li>    <li>But if Western Digital moves forward as it's indicating it will, the move could have an impact on Marvell (<a href=\"http://seekingalpha.com/symbol/MRVL\" target=\"_blank\">MRVL</a> <font color='green'>+2.3%</font>), as well as processor IP companies including Synopsys (<a href=\"http://seekingalpha.com/symbol/SNPS\" target=\"_blank\">SNPS</a> <font color='green'>+0.8%</font>), Cadence Design (<a href=\"http://seekingalpha.com/symbol/CDNS\" target=\"_blank\">CDNS</a> <font color='green'>+1.4%</font>), Imagination Tech and even CEVA (<a href=\"http://seekingalpha.com/symbol/CEVA\" target=\"_blank\">CEVA</a> <font color='green'>+4.4%</font>).</li>    <li>Mobley plans to hold a conference call about RISC-V Jan. 22, <i>Barron's</i> Tiernan Ray notes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320988\" data-linked=\"Benchmark: WDC, NVDA adding fuel to RISC-V movement\" data-tweet=\"$WDC $WDC $NVDA - Benchmark: WDC, NVDA adding fuel to RISC-V movement https://seekingalpha.com/news/3320988-benchmark-wdc-nvda-adding-fuel-to-risc-v-movement?source=tweet\" data-url=\"https://seekingalpha.com/news/3320988-benchmark-wdc-nvda-adding-fuel-to-risc-v-movement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320984\" data-ts=\"1515002425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320984-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='green'>+137%</font>. <a href='https://seekingalpha.com/symbol/JTPY' title='JetPay Corporation'>JTPY</a> <font color='green'>+9%</font>.<a href='https://seekingalpha.com/symbol/SVBI' title='Severn Bancorp Inc'>SVBI</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/IMH' title='Impac Mortgage Holdings, Inc.'>IMH</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CUBI' title='Customers Bancorp'>CUBI</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties'>IIPR</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/FAC' title='First Acceptance Corporation'>FAC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/LMFA' title='LM Funding America, Inc.'>LMFA</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320984\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$HGSH $JTPY $SVBI - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3320984-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3320984-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320983\" data-ts=\"1515002344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSTO\" target=\"_blank\">VSTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320983-firearm-background-checks-down-8-in-dec\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Firearm background checks down 8% in Dec.</a></h4><ul><li>Gun-related stocks react after the latest report from the FBI on background checks indicates a 7.7% drop in December to 2.586M vs. 2.771M a year ago.</li><li>NICS checks fell to 25.235M in 2017 from 27.538M in 2016.</li><li><a href=\"https://www.fbi.gov/file-repository/nics_firearm_checks_-_month_year.pdf/view\" target=\"_blank\">NICS firearm checks data&nbsp;</a></li><li>Sector watch:&nbsp;Vista Outdoor (<a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor'>VSTO</a> <font color='red'>-4.7%</font>), American Outdoor Brands (<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a> <font color='red'>-7.7%</font>), Sturm Ruger (<a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company Inc.'>RGR</a> <font color='red'>-5.5%</font>), Sportsman's Warehouse (<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='red'>-1.8%</font>), Shotspotter (<a href='https://seekingalpha.com/symbol/STI' title='SunTrust Banks, Inc.'>STI</a> <font color='green'>+0.7%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3320983\" data-linked=\"Firearm background checks down 8% in Dec.\" data-tweet=\"$VSTO $VSTO $AOBC - Firearm background checks down 8% in Dec. https://seekingalpha.com/news/3320983-firearm-background-checks-down-8-in-dec?source=tweet\" data-url=\"https://seekingalpha.com/news/3320983-firearm-background-checks-down-8-in-dec\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320978\" data-ts=\"1515001627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320978-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='green'>+132%</font>. <a href='https://seekingalpha.com/symbol/CHCI' title='Comstock Homebuilding Companies, Inc.'>CHCI</a> <font color='green'>+45%</font>. <a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/SCG' title='SCANA Corporation'>SCG</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/REXX' title='Rex Energy Corporation'>REXX</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences'>CHRS</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='green'>+16%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties'>IIPR</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/AMPE' title='Ampio Pharmaceuticals, Inc.'>AMPE</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/BURG' title='Chanticleer Holdings'>BURG</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320978\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$HGSH $CHCI $ARWR - Midday Gainers / Losers https://seekingalpha.com/news/3320978-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3320978-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320973\" data-ts=\"1514999899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUBI\" target=\"_blank\">CUBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320973-customers-bancorp-up-4-after-outlining-tax-benefits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Customers Bancorp up 4% after outlining tax benefits</a></h4><ul><li>The lender <a href=\"https://seekingalpha.com/news/3320827-customers-bancorp-outlines-impacts-u-s-tax-reform\" target=\"_blank\">this morning said</a> it expects the cut in the corporate tax rate to boost earnings by 22% next year.</li><li>B Riley's Steve Moss lifts his 2018 EPS estimate to $2.55 from $2.10 and 2019 to $3.30 from $2.80. Alongside, he boosts his price target to $41 from $35, suggesting about&nbsp;<font color='green'>another 50% upside&nbsp;</font>from the current price.</li><li><a href='https://seekingalpha.com/symbol/CUBI' title='Customers Bancorp'>CUBI</a> today is&nbsp;<font color='green'>up 4%</font>&nbsp;to $27.71.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320973\" data-linked=\"Customers Bancorp up 4% after outlining tax benefits\" data-tweet=\"$CUBI - Customers Bancorp up 4% after outlining tax benefits https://seekingalpha.com/news/3320973-customers-bancorp-up-4-after-outlining-tax-benefits?source=tweet\" data-url=\"https://seekingalpha.com/news/3320973-customers-bancorp-up-4-after-outlining-tax-benefits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320972\" data-ts=\"1514999731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WGP\" target=\"_blank\">WGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320972-western-gas-equity-partners-upgraded-to-buy-ubs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Gas Equity Partners upgraded to Buy at UBS</a></h4><ul>     <li>Western Gas Equity Partners (<a href='https://seekingalpha.com/symbol/WGP' title='Western Gas Equity Partners, LP'>WGP</a> <font color='green'>+2.7%</font>) is <a href=\"https://www.streetinsider.com/Upgrades/UBS+Upgrades+Western+Gas+Equity+Partners%2C+LP+%28WGP%29+to+Buy/13645650.html\" target=\"_blank\">upgraded to Buy</a> from Neutral with a $44 price target at UBS, which estimates distribution growth at a ~11.4% compound annual growth rate through 2020, above the peer group average 6.9%, driven by strong distributions from general partner Western Gas Partners (<a href='https://seekingalpha.com/symbol/WES' title='Western Gas Partners, L.P.'>WES</a> <font color='green'>+4%</font>).</li><li>The firm recently added WES to its Top Picks list, citing its attractive valuation including a ~7.4% yield and growth profile it believes is sustainable, particularly as WES invests most of its capex  into projects in the Delaware and DJ basins.</li><li>UBS also notes Anadarko Petroleum (<a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color='green'>+0.9%</font>), which owns the majority of WGP, has been a supportive sponsor and has been spending capex on midstream assets, which  could provide a potential dropdown opportunity in the future with upside potential for the firm's estimates.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320972\" data-linked=\"Western Gas Equity Partners upgraded to Buy at UBS\" data-tweet=\"$WGP $WGP-OLD $WES - Western Gas Equity Partners upgraded to Buy at UBS https://seekingalpha.com/news/3320972-western-gas-equity-partners-upgraded-to-buy-ubs?source=tweet\" data-url=\"https://seekingalpha.com/news/3320972-western-gas-equity-partners-upgraded-to-buy-ubs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320967\" data-ts=\"1514999019\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320967-semis-start-strong-in-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semis start strong in 2018</a></h4><ul><li>It was a rough end to the year for the previously high-flying chip names as the SOX&nbsp;<font color='red'>dipped 6.6%</font>&nbsp;post-Thanksgiving (still&nbsp;<font color='green'>rising more than 40%</font>&nbsp;in 2017).</li><li>In about one-and-a-half sessions in 2018, though, the gauge has&nbsp;<font color='green'>gained nearly 4%</font>. Numbers yesterday from the Semiconductor Industry Association showed global chip sales of $37.7B in November - up 21.5% Y/Y on a rolling three-month basis, and the strongest-ever monthly sales.</li><li>Leading the chip names today is AMD,&nbsp;<font color='green'>up 7%</font>&nbsp;after a report on <a href=\"https://seekingalpha.com/news/3320844-amd-plus-6_7-percent-intel-chip-flaw-report\" target=\"_blank\">a security flaw in</a> Intel chips. Intel is dragging,&nbsp;<font color='red'>down 3.9%</font>.</li><li><a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>&nbsp;<font color='green'>+0.85%</font></li><li>Source: Bloomberg's Beth Mellor</li><li>ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='PowerShares Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3320967\" data-linked=\"Semis start strong in 2018\" data-tweet=\"$SOXX $SOXL $SMH - Semis start strong in 2018 https://seekingalpha.com/news/3320967-semis-start-strong-in-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3320967-semis-start-strong-in-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320965\" data-ts=\"1514998846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320965-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> XNY <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/DORM' title='Dorman Products, Inc.'>DORM</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/NTZ' title='Natuzzi S.p.A.'>NTZ</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/SYPR' title='Sypris Solutions, Inc.'>SYPR</a> <font color='green'>+10%</font>. LTEA <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley'>VRA</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320965\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$DXF $DORM $NTZ - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3320965-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3320965-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320959\" data-ts=\"1514998184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUN\" target=\"_blank\">SUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320959-sunocos-mariner-east-pipeline-project-halted-pennsylvania-regulator\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunoco&#39;s Mariner East pipeline project halted by Pennsylvania regulator</a></h4><ul>     <li>The Pennsylvania Department of Environmental Protection <a href=\"http://www.philly.com/philly/business/energy/dep-suspends-construction-mariner-east-shale-pipeline-20180103.html\" target=\"_blank\">suspends construction</a> of Sunoco&rsquo;s (<a href='https://seekingalpha.com/symbol/SUN' title='Sunoco LP'>SUN</a> <font color='green'>+1.6%</font>) $2.5B Mariner East shale pipeline project until the company meets certain conditions, such as addressing its effect on private water wells.</li>     <li>&ldquo;Until Sunoco can demonstrate that the permit conditions can and will be followed, DEP has no alternative but to suspend the permits,&rdquo; says the state regulator, which has been critical of the company for sloppy work.</li>     <li>The pipeline is planned to carry natural gas from Pennsylvania's Marcellus Shale to an export terminal near Philadelphia.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320959\" data-linked=\"Sunoco&#39;s Mariner East pipeline project halted by Pennsylvania regulator\" data-tweet=\"$SUN - Sunoco&#39;s Mariner East pipeline project halted by Pennsylvania regulator https://seekingalpha.com/news/3320959-sunocos-mariner-east-pipeline-project-halted-pennsylvania-regulator?source=tweet\" data-url=\"https://seekingalpha.com/news/3320959-sunocos-mariner-east-pipeline-project-halted-pennsylvania-regulator\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320955\" data-ts=\"1514997352\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LBCC\" target=\"_blank\">LBCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320955-investors-eye-iced-tea-to-blockchain-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors eye iced tea to blockchain stock</a></h4><ul>     <li>Long Blockchain (LTEA) continues to be a high volume, high volatility cryptocurrency play after pivoting from selling iced tea products.</li>     <li>Today is the fourth day in a row that the stock has pushed higher.</li>     <li>While there are no Wall Street analysts covering LTEA, there's been some <a href=\"https://seekingalpha.com/pr/17032581-long-island-iced-tea-corp-rebrand-long-blockchain-corp\" target=\"_blank\">discussion</a> on Seeking Alpha on what to make of the blockchain upstart.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320955\" data-linked=\"Investors eye iced tea to blockchain stock\" data-tweet=\"$LBCC - Investors eye iced tea to blockchain stock https://seekingalpha.com/news/3320955-investors-eye-iced-tea-to-blockchain-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3320955-investors-eye-iced-tea-to-blockchain-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320954\" data-ts=\"1514997248\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETN\" target=\"_blank\">ETN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320954-eaton-upgraded-baird-on-tax-clarity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eaton upgraded by Baird on tax clarity</a></h4><ul>     <li>Eaton (<a href='https://seekingalpha.com/symbol/ETN' title='Eaton Corp. plc'>ETN</a> <font color='green'>+1.8%</font>) is up after Baird <a href=\"https://www.streetinsider.com/Analyst+Comments/Baird+Upgrades+Eaton+Corporation+%28ETN%29+to+Outperform/13646456.html\" target=\"_blank\">upgrades</a> shares to Outperform from Neutral and raises its stock price target to $92 from $82, saying tax clarity could allow the company to close its valuation gap vs. peers.</li>     <li>Baird says ETN was the first company in its coverage to clarify the impact of the tax law changes on its near-term and longer-term tax rate, and the firm says in essence the impact is modest, with ETN continuing to benefit from one of the lowest tax rates in its coverage.</li>     <li><a href=\"https://seekingalpha.com/news/3320718-eaton-slips-stifel-slashes-eps-estimate-new-tax-law\" target=\"_blank\">Yesterday</a>, Stifel analysts cut its 2018 EPS estimate for ETN, saying the new U.S. tax law will increase the company&rsquo;s rate.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320954\" data-linked=\"Eaton upgraded by Baird on tax clarity\" data-tweet=\"$ETN - Eaton upgraded by Baird on tax clarity https://seekingalpha.com/news/3320954-eaton-upgraded-baird-on-tax-clarity?source=tweet\" data-url=\"https://seekingalpha.com/news/3320954-eaton-upgraded-baird-on-tax-clarity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320950\" data-ts=\"1514996770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPH\" target=\"_blank\">SPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320950-suburban-propane-upgraded-to-buy-ubs-cold-january-positive\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Suburban Propane upgraded to Buy at UBS as cold January a positive</a></h4><ul>     <li>Suburban Propane (<a href='https://seekingalpha.com/symbol/SPH' title='Suburban Propane Partners LP'>SPH</a> <font color='green'>+2.6%</font>) is higher after UBS <a href=\"https://www.streetinsider.com/Analyst+PT+Change/UBS+Upgrades+Suburban+Propane+%28SPH%29+to+Buy/13645647.html\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with a $29 price target, raised from $26, saying the colder than normal January weather is a positive for SPH's asset footprint as it is heavily weighed to the U.S. northeast.</li><li>The  firm notes January historically has represented ~20% of SPH's heating degree days for the year, so a colder January should prove to be a positive for cash flows, while a normal winter would be a stark contrast to the last two years which caused SPH's leverage to lift and ultimately resulted in a distribution cut.</li><li>UBS expects rising propane prices to result in some margin compression during the year, but if SPH can manage margins and grow volumes at the same time, it foresees upside to its estimates.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3320950\" data-linked=\"Suburban Propane upgraded to Buy at UBS as cold January a positive\" data-tweet=\"$SPH - Suburban Propane upgraded to Buy at UBS as cold January a positive https://seekingalpha.com/news/3320950-suburban-propane-upgraded-to-buy-ubs-cold-january-positive?source=tweet\" data-url=\"https://seekingalpha.com/news/3320950-suburban-propane-upgraded-to-buy-ubs-cold-january-positive\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320949\" data-ts=\"1514996764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUAN\" target=\"_blank\">NUAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320949-nuance-notes-enhancements-to-driving-platform-new-ai-features\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nuance notes enhancements to driving platform, new AI features</a></h4><ul>   <li>Among a set of new product announcements, Nuance Communications (<a href=\"http://seekingalpha.com/symbol/NUAN\" target=\"_blank\">NUAN</a> <font color='green'>+1.7%</font>) is rolling out <a href=\"https://seekingalpha.com/pr/17036596-nuance-announces-new-ai-powered-dragon-drive-features-transform-automotive-experience\" target=\"_blank\">new AI capabilities</a> for its automotive voice platform Dragon Drive.</li>    <li>That will now integrate \"non-verbal modalities\" including gaze detection along with increased interoperability with other assistants. It will also be able to be invoked with a wake-up word, similar to smart speakers like the Amazon Echo or Google Home.</li>    <li>The company also announced a new \"<a href=\"https://seekingalpha.com/pr/17036594-brains-better-one-nuance-s-new-cognitive-arbitrator-connects-virtual-assistants-smart-home\" target=\"_blank\">cognitive arbitrator</a>,\" an AI capability to integrate vocabularies and capabilities among virtual assistants spread over numerous devices and services.</li>    <li>It's meant to hear a user's request and route it to an assistant or service best suited to accomplish a given task (whether in-car assistance for driving directions or specialized assistants to handle shopping or banking).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320949\" data-linked=\"Nuance notes enhancements to driving platform, new AI features\" data-tweet=\"$NUAN - Nuance notes enhancements to driving platform, new AI features https://seekingalpha.com/news/3320949-nuance-notes-enhancements-to-driving-platform-new-ai-features?source=tweet\" data-url=\"https://seekingalpha.com/news/3320949-nuance-notes-enhancements-to-driving-platform-new-ai-features\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320947\" data-ts=\"1514996347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/W\" target=\"_blank\">W</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320947-wayfair-lower-after-baml-raises-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wayfair lower after BAML raises concerns</a></h4><ul> <li>Wayfair (NYSE:<a href='https://seekingalpha.com/symbol/W' title='Wayfair'>W</a>) is <font color='red'>down 4.74%</font> on high volume after Bank of America Merrill Lynch drops its rating to <a href=\"https://www.barrons.com/articles/morning-movers-dominion-moneygram-sink-oracle-gains-1514988254\" target=\"_blank\">Neutral</a> from Buy.</li> <li>BAML joins the crowd warning on Wayfair's valuation and sees a tough year of sales comparable ahead for the retailer. Another thought from the BAML analyst team is that the aggressive online push by Walmart could add pressure to the growth story.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3320947\" data-linked=\"Wayfair lower after BAML raises concerns\" data-tweet=\"$W - Wayfair lower after BAML raises concerns https://seekingalpha.com/news/3320947-wayfair-lower-after-baml-raises-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3320947-wayfair-lower-after-baml-raises-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320902\" data-ts=\"1514995279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320902-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/DMPI' title='DelMar Pharmaceuticals, Inc.'>DMPI</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences'>CHRS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/BVXV' title='Biondvax Pharmaceuticals'>BVXV</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/AMPE' title='Ampio Pharmaceuticals, Inc.'>AMPE</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320902\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$INSYQ $DMPI $GALT - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3320902-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3320902-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320933\" data-ts=\"1514994276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNBT\" target=\"_blank\">GNBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320933-generex-acquires-two-retail-pharmacy-operations-shares-up-26\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Generex acquires two retail pharmacy operations; shares up 26%</a></h4><ul><li>Following through on its strategy to establish a footprint in the U.S. direct-to-consumer pharmaceuticals business, Generex Biotechnology (<a href='https://seekingalpha.com/symbol/GNBT' title='Generex Biotechnology Corp.'>OTCQB:GNBT</a> <font color='green'>+26%</font>) <a href=\"https://seekingalpha.com/pr/17036799-generex-announces-initial-pharmacy-acquisitions-and-plans-broader-acquisitions-strategy\" target=\"_blank\">acquires </a>two pre-operational retail pharmacy operations: Empire State Pharmacy in New York and Grainland Pharmacy in Kansas. Both should be fully operational this quarter.</li><li>Financial terms are not disclosed.</li><li>The company says it plans to establish a nationwide presence in the space through its wholly owned subsidiary NuGenerex Distribution Solutions, LLC.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320933\" data-linked=\"Generex acquires two retail pharmacy operations; shares up 26%\" data-tweet=\"$GNBT - Generex acquires two retail pharmacy operations; shares up 26% https://seekingalpha.com/news/3320933-generex-acquires-two-retail-pharmacy-operations-shares-up-26?source=tweet\" data-url=\"https://seekingalpha.com/news/3320933-generex-acquires-two-retail-pharmacy-operations-shares-up-26\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320926\" data-ts=\"1514993493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZSAN\" target=\"_blank\">ZSAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320926-zosano-nabs-u-s-patent-covering-migraine-candidate-m207-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zosano nabs U.S. patent covering migraine candidate M207; shares up 2%</a></h4><ul><li>The USPTO <a href=\"https://seekingalpha.com/pr/17036691-zosano-pharma-announces-notice-allowance-u-s-patent-application-covering-m207-acute-treatment\" target=\"_blank\">issues </a>a Notice of Allowance to Zosano Pharma (<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+1.9%</font>) for its patent application entitled \"Method of Rapidly Achieving Therapeutic Concentrations of Triptans for Treatment of Migraines.\" The patent covers lead candidate M207, currently in <a href=\"https://clinicaltrials.gov/ct2/show/NCT03282227?term=m207&amp;rank=1\" target=\"_blank\">Phase 3</a> development.</li><li>M207 is a zolmitriptan-coated microneedle patch is that is designed to rapidly deliver zolmitriptan during a migraine attack.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3295172-zosanos-m207-shows-treatment-effect-late-stage-migraine-study-shares-ahead-19-percent\" target=\"_blank\">Zosano's M207 shows treatment effect in late-stage migraine study; shares ahead 19%</a> (Sept. 13, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3320926\" data-linked=\"Zosano nabs U.S. patent covering migraine candidate M207; shares up 2%\" data-tweet=\"$ZSAN - Zosano nabs U.S. patent covering migraine candidate M207; shares up 2% https://seekingalpha.com/news/3320926-zosano-nabs-u-s-patent-covering-migraine-candidate-m207-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3320926-zosano-nabs-u-s-patent-covering-migraine-candidate-m207-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320927\" data-ts=\"1514993490\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNW\" target=\"_blank\">GNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320927-genworth-down-nearly-5-trump-shuts-door-on-china-deals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genworth down nearly 5% as Trump &#39;shuts door&#39; on China deals</a></h4><ul><li>MoneyGram is&nbsp;<font color='red'>lower by 8.6%</font>&nbsp;after it and China's Ant Financial <a href=\"https://seekingalpha.com/news/3320761-moneygram-minus-9_7-percent-ant-financial-merger-called\" target=\"_blank\">terminated their</a> merger deal in the face of U.S. government opposition.</li><li>The merits of the deal are irrelevant, says Cowen's Jaret Seiberg. Instead its a \"de facto ban\" on CFIUS approving and China-related financial deals. \"Trump appears to have shut that door.\"</li><li>The move is leaving some to question whether the Genworth (<a href='https://seekingalpha.com/symbol/GNW' title='Genworth Financial, Inc.'>GNW</a> <font color='red'>-4.6%</font>)/Ocwenwide merger will ever consummate.</li><li>Source: Bloomberg's Joshua Fineman</li></ul><div class=\"tiny-share-widget\" data-id=\"3320927\" data-linked=\"Genworth down nearly 5% as Trump &#39;shuts door&#39; on China deals\" data-tweet=\"$GNW - Genworth down nearly 5% as Trump &#39;shuts door&#39; on China deals https://seekingalpha.com/news/3320927-genworth-down-nearly-5-trump-shuts-door-on-china-deals?source=tweet\" data-url=\"https://seekingalpha.com/news/3320927-genworth-down-nearly-5-trump-shuts-door-on-china-deals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320923\" data-ts=\"1514992849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSPR\" target=\"_blank\">NSPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320923-inspiremds-cguard-eps-okd-in-india-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InspireMD&#39;s CGuard EPS OK&#39;d in India; shares up 6%</a></h4><ul><li>India's Ministry of Health &amp; Family Welfare <a href=\"https://seekingalpha.com/pr/17036765-inspiremd-announces-regulatory-approval-cguard-eps-india-signs-agreement-leading-indian\" target=\"_blank\">approves </a>InspireMD's (<a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a> <font color='green'>+6.4%</font>) CGuard Embolic Prevention System &#40;EPS&#41;.</li><li>Hester Diagnostics Pvt. Ltd. will distribute.</li><li>The company says the <a href=\"http://www.inspiremd.com/en/product/cguard/\" target=\"_blank\">CGuard </a>stent is designed to prevent embolization (blocking a blood vessel) by trapping potential emboli against the arterial wall while maintaining excellent blood flow.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320923\" data-linked=\"InspireMD&#39;s CGuard EPS OK&#39;d in India; shares up 6%\" data-tweet=\"$NSPR - InspireMD&#39;s CGuard EPS OK&#39;d in India; shares up 6% https://seekingalpha.com/news/3320923-inspiremds-cguard-eps-okd-in-india-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3320923-inspiremds-cguard-eps-okd-in-india-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320922\" data-ts=\"1514992579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKX\" target=\"_blank\">SKX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320922-sizzling-read-on-skechers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sizzling read on Skechers</a></h4><ul> <li>Channel checks by Wedbush on Skechers (<a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='green'>+1.9%</font>) came back glowing hot to set up the retailer for a a strong 2018.</li> <li>The Wedbush team led by analyst Christopher Svezia reiterates an <a href=\"https://www.marketwatch.com/story/skechers-global-business-accelerating-prompting-price-target-boost-2018-01-03\" target=\"_blank\">Outperform rating</a> on the stock and lifts its price target to $45 from $39.</li> <li>\"The stronger top line, coupled with a margin story less reliant on SG&amp;A leverage for fiscal 2018 leave us bullish on the shares,\" reads Svezia's note.</li> <li>Last year, Skechers ran up a 54% return to smash the 19% average in the footwear and accesories category.</li> <li>Sources: Morningstar and MarketWatch</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320922\" data-linked=\"Sizzling read on Skechers\" data-tweet=\"$SKX - Sizzling read on Skechers https://seekingalpha.com/news/3320922-sizzling-read-on-skechers?source=tweet\" data-url=\"https://seekingalpha.com/news/3320922-sizzling-read-on-skechers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320917\" data-ts=\"1514992120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320917-fda-signs-off-on-phase-3-protocol-for-omeros-oms721-in-iga-nephropathy-shares-up-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA signs off on Phase 3 protocol for Omeros&#39; OMS721 in IgA nephropathy; shares up 9%</a></h4><ul><li>Omeros (<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+8.7%</font>) has reached <a href=\"https://seekingalpha.com/pr/17036431-omeros-corporation-reaches-agreement-fda-oms721-phase-3-trial-protocol-iga-nephropathy\" target=\"_blank\">agreement </a>with the FDA on the design of a Phase 3 clinical trial assessing OMS721 in patients with IgA nephropathy (IgAN).</li><li>The randomized, double-blind, placebo-controlled study will enroll adult patients with biopsy-confirmed IgAN and 24-hour urine protein excretion greater than 1 g/day at baseline. The primary endpoint is the reduction in proteinuria at week 24. The study should launch next month.</li><li>Orphan Drug- and Breakthrough Therapy-tagged OMS721 binds to an enzyme called mannan-binding lectin-associated serine protease-2 (<a href=\"http://www.omeros.com/pipeline/masp.htm\" target=\"_blank\">MASP-2</a>) which plays a key role in the lectin pathway of the complement system, which is believed to contribute to significant tissue injury.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3289083-omeros-oms721-continues-demonstrate-treatment-benefit-one-year-iga-nephropathy-patients\" target=\"_blank\">Omeros' OMS721 continues to demonstrate treatment benefit after one year in IgA nephropathy patients; shares ahead 5%</a> (Aug. 14, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3320917\" data-linked=\"FDA signs off on Phase 3 protocol for Omeros&#39; OMS721 in IgA nephropathy; shares up 9%\" data-tweet=\"$OMER - FDA signs off on Phase 3 protocol for Omeros&#39; OMS721 in IgA nephropathy; shares up 9% https://seekingalpha.com/news/3320917-fda-signs-off-on-phase-3-protocol-for-omeros-oms721-in-iga-nephropathy-shares-up-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3320917-fda-signs-off-on-phase-3-protocol-for-omeros-oms721-in-iga-nephropathy-shares-up-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320914\" data-ts=\"1514991941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320914-pareteumplus-20-after-announcing-record-backlog-for-2017\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum +20% after announcing record backlog for 2017</a></h4><ul>   <li>Pareteum (NYSEMKT:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) -- making most of its moves lately due to its tiptoes into blockchain capabilities -- is <font color='green'>up 20.3%</font> this morning after noting it wrapped 2017 with a <a href=\"https://seekingalpha.com/pr/17036554-pareteum-ends-2017-record-147-million-contractual-revenue-backlog\" target=\"_blank\">record revenue backlog</a>.</li>    <li>The company (the former Elephant Talk Communications) executed deals that bring total 36-month contractual revenue backlog to $147M, after signing 28 new agreements in 2017.</li>    <li>Those new deals made up $117M of the backlog.</li>    <li>Q4 marks a 58% sequential gain in contract agreement executions, and compound annual growth rate of the backlog is 389% since Jan. 1, 2017, the company notes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320914\" data-linked=\"Pareteum +20% after announcing record backlog for 2017\" data-tweet=\"$TEUM - Pareteum +20% after announcing record backlog for 2017 https://seekingalpha.com/news/3320914-pareteumplus-20-after-announcing-record-backlog-for-2017?source=tweet\" data-url=\"https://seekingalpha.com/news/3320914-pareteumplus-20-after-announcing-record-backlog-for-2017\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320909\" data-ts=\"1514991543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320909-rokuplus-6-broadens-licensing-home-entertainment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku +6% as it broadens licensing into home entertainment</a></h4><ul>    <li>Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a>) shares are <font color='green'>up 6.1%</font> after it's <a href=\"https://seekingalpha.com/pr/17036801-roku-unveils-whole-home-entertainment-licensing-program-enable-oem-brands-build-audio-devices\" target=\"_blank\">announced a licensing program</a> providing for OEM brands to build home entertainment device makers to build around the Roku Connect software.</li>    <li>That could mean smart speakers and soundbars along with multi-room audio systems and TVs working together with wireless connections and controlled by a voice remote.</li>    <li>Lead OEM partner TCL will announce plans to offer the first device under the program at CES on Monday.</li>    <li>The company unveiled a TV licensing program four years ago, but with that now \"flourishing,\" the new program represents an expansion further into home theater control.</li>    <li>A voice remote would be powered by the newly announced Roku Entertainment Assistant, rolling out as a free update to the Roku OS by this fall.</li>    <li>Roku's also announced a <a href=\"https://seekingalpha.com/pr/17036889-funai-electric-roku-announce-plans-bring-magnavox-roku-tvs-market\" target=\"_blank\">deal with Funai Electric</a> (<a href='https://seekingalpha.com/symbol/FUAIY' title='Funai Electric Co. Ltd. ADR'>OTCPK:FUAIY</a>) to bring the Magnavox brand into the licensing agreement, allowing for Magnavox TVs featuring the Roku OS as soon as this spring.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320909\" data-linked=\"Roku +6% as it broadens licensing into home entertainment\" data-tweet=\"$ROKU $ROKU $FUAIY - Roku +6% as it broadens licensing into home entertainment https://seekingalpha.com/news/3320909-rokuplus-6-broadens-licensing-home-entertainment?source=tweet\" data-url=\"https://seekingalpha.com/news/3320909-rokuplus-6-broadens-licensing-home-entertainment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320901\" data-ts=\"1514990803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320901-blackberryplus-6-qnx-to-anchor-baidu-self-driving-cars\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry +6% with QNX to anchor Baidu self-driving cars</a></h4><ul>   <li>BlackBerry (NYSE:<a href='https://seekingalpha.com/symbol/BB' title='BlackBerry Ltd.'>BB</a>) has come out of the session open <font color='green'>up 6%</font> after more connected-car news, with reports that its QNX will <a href=\"https://venturebeat.com/2018/01/03/blackberrys-qnx-os-to-be-the-bedrock-of-baidus-apollo-autonomous-driving-platform/\" target=\"_blank\">anchor the Apollo autonomous driving platform</a> at Baidu (<a href=\"http://seekingalpha.com/symbol/BIDU\" target=\"_blank\">BIDU</a> <font color='red'>-0.7%</font>) in a key win.</li>    <li>Baidu will integrate its own software into the QNX infotainment program as part of the collaboration.</li>    <li>Apollo -- what Baidu thinks of as the \"Android of the autonomous driving industry\" -- has partners including Ford, Intel, Nvidia, and Microsoft.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320901\" data-linked=\"BlackBerry +6% with QNX to anchor Baidu self-driving cars\" data-tweet=\"$BB $BB $BIDU - BlackBerry +6% with QNX to anchor Baidu self-driving cars https://seekingalpha.com/news/3320901-blackberryplus-6-qnx-to-anchor-baidu-self-driving-cars?source=tweet\" data-url=\"https://seekingalpha.com/news/3320901-blackberryplus-6-qnx-to-anchor-baidu-self-driving-cars\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>158&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320900\" data-ts=\"1514990802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WKHS\" target=\"_blank\">WKHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320900-workhorse-gets-faa-certification-for-electric-hybrid-helicopter-test-flights\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workhorse gets FAA certification for electric hybrid helicopter test flights</a></h4><ul>     <li>Workhorse (<a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='green'>+4.4%</font>) opens higher after receiving an Experimental Airworthiness Certificate from the FAA that will allow the company to <a href=\"https://seekingalpha.com/pr/17036907-workhorse-receives-faa-certification-test-flights-surefly-electric-hybrid-helicopter\" target=\"_blank\">conduct test flights</a> of its SureFly electric hybrid helicopter.</li>     <li>WKHS says the first test flight is scheduled for Jan. 8 in Las Vegas, prior to the start of the 2018 Consumer Electronic Show.</li>     <li>SureFly, first unveiled at the Paris Air Show last June, features a  drone-like octocopter design, a two-person, 400-pound payload capacity  and a range of ~70 miles.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320900\" data-linked=\"Workhorse gets FAA certification for electric hybrid helicopter test flights\" data-tweet=\"$WKHS - Workhorse gets FAA certification for electric hybrid helicopter test flights https://seekingalpha.com/news/3320900-workhorse-gets-faa-certification-for-electric-hybrid-helicopter-test-flights?source=tweet\" data-url=\"https://seekingalpha.com/news/3320900-workhorse-gets-faa-certification-for-electric-hybrid-helicopter-test-flights\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320895\" data-ts=\"1514989444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320895-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/SCG' title='SCANA Corporation'>SCG</a> <font color='green'>+23%</font>&nbsp;on stock <a href=\"https://seekingalpha.com/news/3320828-dominion-energy-scana-agree-stock-merger\" target=\"_blank\">merger</a> with Dominion Energy (NYSE:<a href='https://seekingalpha.com/symbol/D' title='Dominion Energy, Inc.'>D</a>).</li>     <li><a href='https://seekingalpha.com/symbol/TRVN' title='Trevena, Inc.'>TRVN</a> <font color='green'>+17%</font>&nbsp;as FDA <a href=\"https://seekingalpha.com/news/3320768-fda-accepts-trevenas-marketing-application-pain-med-olinvo-shares-ahead-17-percent-hours\" target=\"_blank\">accepts</a> Trevena's marketing application for pain med Olinvo.</li>     <li><a href='https://seekingalpha.com/symbol/JTPY' title='JetPay Corporation'>JTPY</a> <font color='green'>+16%.</font></li>     <li><a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='green'>+14%</font>&nbsp;on sale <a href=\"https://seekingalpha.com/pr/17036720-oti-announces-outstanding-increase-2017-smart-atm-sales-recognizes-potential-2018\" target=\"_blank\">growth</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CNIT-OLD' title='China Information Technology'>CNIT-OLD</a> <font color='green'>+13%</font>&nbsp;on $1.5M&nbsp;cloud-based ad terminals&nbsp;<a href=\"https://seekingalpha.com/pr/17036628-cnit-receives-1_5-million-cloud-based-ad-terminal-order-hebei-liaoning-province\" target=\"_blank\">order</a>.</li>     <li><a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a> <font color='green'>+12%</font>&nbsp;as FDA <a href=\"https://seekingalpha.com/pr/17036648-vistagen-therapeutics-receives-fda-fast-track-designation-avminus-101-treatment-major\" target=\"_blank\">grants</a> Fast Track Designation to AV-101 for development as a potential adjunctive treatment for Major Depressive Disorder.</li>     <li><a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a> <font color='green'>+11%</font>&nbsp;on $147M contractual revenue <a href=\"https://seekingalpha.com/pr/17036554-pareteum-ends-2017-record-147-million-contractual-revenue-backlog\" target=\"_blank\">backlog</a>.</li>     <li><a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a> <font color='green'>+10%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='green'>+8%</font>&nbsp;on Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTL' title='INTL FCStone Inc.'>INTL</a>) chip flaw <a href=\"https://seekingalpha.com/news/3320844-amd-plus-6_7-percent-intel-chip-flaw-report\" target=\"_blank\">report</a>.</li>     <li><a href='https://seekingalpha.com/symbol/TTPH' title='Tetraphase Pharmaceuticals'>TTPH</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3320783-tetraphase-pharma-submits-nda-intra-abdominal-infections-fda\" target=\"_blank\">submitting</a> NDA for intra-abdominal infections to FDA.</li>     <li><a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a> <font color='green'>+5%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3320816-commercial-metals-beats-0_13-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320895\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$SCG $D $TRVN - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3320895-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3320895-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320894\" data-ts=\"1514989434\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320894-valeant-pays-down-additional-300m-of-debt-shares-ahead-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant pays down additional $300M of debt; shares ahead 3% premarket</a></h4><ul><li>Valeant Pharmaceuticals (VRX) <a href=\"https://seekingalpha.com/pr/17036846-valeant-pays-300-million-senior-secured-term-loans\" target=\"_blank\">announces</a> that it has paid down an additional $300M of its outstanding senior secured term loans using cash on hand. It has now reduced its debt by more than $6.5B since Q1 2016.</li><li>At year-end 2017, the company's total debt was ~$25.7B.</li><li>Shares are up&nbsp;<font color='green'>3%&nbsp;</font>premarket on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320894\" data-linked=\"Valeant pays down additional $300M of debt; shares ahead 3% premarket\" data-tweet=\"$BHC - Valeant pays down additional $300M of debt; shares ahead 3% premarket https://seekingalpha.com/news/3320894-valeant-pays-down-additional-300m-of-debt-shares-ahead-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3320894-valeant-pays-down-additional-300m-of-debt-shares-ahead-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>95&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320892\" data-ts=\"1514989348\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXTR\" target=\"_blank\">EXTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320892-extreme-networksplus-1_6-jmp-starts-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Extreme Networks +1.6% as JMP starts at Outperform</a></h4><ul>   <li>Extreme Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/EXTR' title='Extreme Networks, Inc.'>EXTR</a>) is <font color='green'>up 1.6%</font> premarket after a launch at Market Outperform by JMP Securities, joining a heavily bullish chorus.</li>    <li>That makes a half-dozen firms at Buy on the stock, which has <font color='green'>gained 183%</font> over the past 12 months.</li>    <li>JMP has a price target of $16 -- in line with other price targets, and implying 26% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320892\" data-linked=\"Extreme Networks +1.6% as JMP starts at Outperform\" data-tweet=\"$EXTR - Extreme Networks +1.6% as JMP starts at Outperform https://seekingalpha.com/news/3320892-extreme-networksplus-1_6-jmp-starts-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3320892-extreme-networksplus-1_6-jmp-starts-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320890\" data-ts=\"1514989129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXPE\" target=\"_blank\">EXPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320890-expediaplus-2_6-bofa-raises-bar-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Expedia +2.6% as BofA raises bar to Buy</a></h4><ul>   <li>Expedia (NASDAQ:<a href='https://seekingalpha.com/symbol/EXPE' title='Expedia, Inc.'>EXPE</a>) is <font color='green'>up 2.6%</font> premarket after an upgrade to Buy at BofA Merrill Lynch, which says the company's set expectations for a \"reasonable and beatable EBITDA bar for 2018.\"</li>    <li>The risk-reward ratio is positive as there's room for increasing penetration in the industry, and the Street may start looking to accelerating growth in 2019, Justin Post writes (h/t Bloomberg).</li>    <li>Its HomeAway unit has a big three-year growth opportunity as well, the firm says.</li>    <li>BofA has set a price target of $145, implying 19.4% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320890\" data-linked=\"Expedia +2.6% as BofA raises bar to Buy\" data-tweet=\"$EXPE - Expedia +2.6% as BofA raises bar to Buy https://seekingalpha.com/news/3320890-expediaplus-2_6-bofa-raises-bar-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3320890-expediaplus-2_6-bofa-raises-bar-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320888\" data-ts=\"1514989083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTGN\" target=\"_blank\">VTGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320888-vistagens-avminus-101-fast-trackd-in-u-s-for-major-depressive-disorder-shares-up-11-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VistaGen&#39;s AV-101 Fast Track&#39;d in U.S. for major depressive disorder; shares up 11% premarket</a></h4><ul><li>Nano cap VistaGen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a>) is up&nbsp;<font color='green'>11%</font>&nbsp;premarket on robust volume on the heels of the FDA <a href=\"https://seekingalpha.com/pr/17036648-vistagen-therapeutics-receives-fda-fast-track-designation-avminus-101-treatment-major\" target=\"_blank\">granting</a> Fast Track status for lead candidate AV-101 for the adjunctive treatment of major depressive disorder &#40;MDD&#41;.</li><li>Fast Track status provides for more frequent interactions with the FDA review team and a rolling review of the marketing application.</li><li>A Phase 2 study should commence this quarter.</li><li><a href=\"http://www.vistagen.com/?page_id=11\" target=\"_blank\">AV-101</a>&nbsp;is an orally available central nervous system &#40;CNS&#41; prodrug that is converted in the brain by cells called&nbsp;<a href=\"https://en.wikipedia.org/wiki/Astrocyte\" target=\"_blank\">astrocytes&nbsp;</a>into its active metabolite, 7-chlorokynurenic acid (7-CI-KYNA), a highly selective antagonist of certain receptors &#40;NMDA&#41;&nbsp;that play key roles in neurodegenerative diseases like epilepsy, MDD and neuropathic pain.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320888\" data-linked=\"VistaGen&#39;s AV-101 Fast Track&#39;d in U.S. for major depressive disorder; shares up 11% premarket\" data-tweet=\"$VTGN - VistaGen&#39;s AV-101 Fast Track&#39;d in U.S. for major depressive disorder; shares up 11% premarket https://seekingalpha.com/news/3320888-vistagens-avminus-101-fast-trackd-in-u-s-for-major-depressive-disorder-shares-up-11-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3320888-vistagens-avminus-101-fast-trackd-in-u-s-for-major-depressive-disorder-shares-up-11-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320887\" data-ts=\"1514988632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320887-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>&nbsp;<font color='red'>-8%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3320811-ant-moneygram-rejection-fading-goodwill\" target=\"_blank\">terminating</a> merger deal with Ant Financial Services Group.</li><li><a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>&nbsp;<font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3320709-bitcoin-attracts-massive-investment-vc-firm\" target=\"_blank\">Bitcoin</a> boom.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3320887\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$MGI $GROW - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3320887-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3320887-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320884\" data-ts=\"1514988416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGMO\" target=\"_blank\">SGMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320884-sangamo-teams-up-pfizer-to-develop-gene-therapy-to-treat-als-shares-ahead-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sangamo teams up with Pfizer to develop gene therapy to treat ALS; shares ahead 4% premarket</a></h4><ul><li>Sangamo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a>) is up&nbsp;<font color='green'>4%</font>&nbsp;premarket on modest volume in response to its <a href=\"https://seekingalpha.com/pr/17036494-sangamo-pfizer-announce-collaboration-development-zinc-finger-protein-gene-therapy-als\" target=\"_blank\">collaboration </a>with Pfizer (NYSE:<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a>) aimed at developing a gene therapy using zinc finger protein transcription factors (ZFP-TFs) to treat amyotrophic lateral sclerosis &#40;ALS&#41; and frontotemporal lobar degeneration &#40;FTLD&#41; linked to mutations of the C90RF72 gene.</li><li>The companies will investigate allele-specific ZFP-TFs to potentially differentiate the mutant C90FR72 allele from the wild type allele and to specifically down-regulate the mutant form.</li><li>Under the terms of the agreement, Sangamo will receive $12M upfront, up to $150M in milestones and tiered royalties on net sales. Sangamo will be responsible for developing ZFP-TF candidates while Pfizer will be responsible for subsequent research, development, manufacturing and commercialization.</li><li>The companies are also collaborating on the development of gene therapies to treat hemophilia A under a May 2017 agreement.</li><li>Sangamo's ZFP-TF technology is designed to down/up-regulate the expression of a specific gene or DNA sequence with a single administration.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320884\" data-linked=\"Sangamo teams up with Pfizer to develop gene therapy to treat ALS; shares ahead 4% premarket\" data-tweet=\"$SGMO $SGMO $PFE - Sangamo teams up with Pfizer to develop gene therapy to treat ALS; shares ahead 4% premarket https://seekingalpha.com/news/3320884-sangamo-teams-up-pfizer-to-develop-gene-therapy-to-treat-als-shares-ahead-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3320884-sangamo-teams-up-pfizer-to-develop-gene-therapy-to-treat-als-shares-ahead-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320877\" data-ts=\"1514987428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASY\" target=\"_blank\">CASY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320877-jcp-investment-pushes-for-sale-caseys-general-stores\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JCP Investment pushes for sale at Casey&#39;s General Stores</a></h4><ul>          <li>JCP Investment Management issues a letter to shareholders of Casey's General Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/CASY' title='Casey&#39;s General Stores, Inc.'>CASY</a>) in which it pushes for the retailer to explore strategic alternatives.</li>     <li>The firm holds about $45M worth of Casey's shares. Key points from JCP's biting letter are posted below.</li>     <li>\"We believe Casey's shares are significantly undervalued as they do not reflect the true earnings power and full real estate value of the Company's irreplaceable fleet of 2,000+ stores.\"</li>     <li>\"Casey's no longer delivers best in class returns as measured by either operating metrics or share price performance.\"</li>     <li>\"Casey's has missed earnings targets for seven straight quarters due in part to decelerating same store sales and bloated operational expenses.\"</li>     <li>\"We believe Casey's shares could be worth from $150 to greater than $170 per share to a potential acquirer. We believe this is realistic given the significant synergies and real estate value that Casey's offers.\"</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/17036666-jcp-issues-letter-shareholders-caseys-general-stores\" target=\"_blank\">Press Release</a></li><li>CASY&nbsp;<font color='green'>+1.17%</font>&nbsp;in light premarket trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320877\" data-linked=\"JCP Investment pushes for sale at Casey&#39;s General Stores\" data-tweet=\"$CASY - JCP Investment pushes for sale at Casey&#39;s General Stores https://seekingalpha.com/news/3320877-jcp-investment-pushes-for-sale-caseys-general-stores?source=tweet\" data-url=\"https://seekingalpha.com/news/3320877-jcp-investment-pushes-for-sale-caseys-general-stores\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320875\" data-ts=\"1514987025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320875-oracleplus-1_4-after-analyst-calls-stock-undervalued\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle +1.4% after analyst calls the stock undervalued</a></h4><ul><li>        Morgan Stanley <a href=\"https://www.cnbc.com/2018/01/03/stocks-making-the-biggest-moves-premarket-baba-ibm-axp-alxn-aal-luv-more.html\" target=\"_blank\">upgrades</a> Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>) from Equal Weight to Overweight.</li><li>               The firm says disappointing cloud-related quarterly results have left the stock undervalued.&nbsp;</li><li>               Latest analyst recommendations: 11 Buy, 15 Outperform, 11 Hold, and 1 Sell.&nbsp;</li><li>               Median price target: $55.50.&nbsp;</li><li>               Oracle shares are<font color='green'>&nbsp;up 1.4%</font>&nbsp;premarket. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320664-information-amazon-salesforce-seeking-oracle-alternatives\" target=\"_blank\">The Information: Amazon, Salesforce seeking Oracle alternatives</a> (Jan. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3320875\" data-linked=\"Oracle +1.4% after analyst calls the stock undervalued\" data-tweet=\"$ORCL - Oracle +1.4% after analyst calls the stock undervalued https://seekingalpha.com/news/3320875-oracleplus-1_4-after-analyst-calls-stock-undervalued?source=tweet\" data-url=\"https://seekingalpha.com/news/3320875-oracleplus-1_4-after-analyst-calls-stock-undervalued\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320872\" data-ts=\"1514986600\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ULTA\" target=\"_blank\">ULTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320872-wells-fargo-sees-compelling-setup-for-ulta-beauty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo sees &#39;compelling setup&#39; for Ulta Beauty</a></h4><ul> <li>Wells Fargo <a href=\"https://www.streetinsider.com/Analyst+Comments/Wells+Fargo+Upgrades+ULTA+Salon+%28ULTA%29+to+Outperform+Citing+a+Compelling+Setup/13645588.html\" target=\"_blank\">upgrades</a> Ulta Beauty (NASDAQ:<a href='https://seekingalpha.com/symbol/ULTA' title='Ulta Beauty, Inc.'>ULTA</a>) to an Outperform rating from Market Perform on what the analyst team calls a \"compelling setup\" for 2018.</li> <li>The investment firm assigns a price target of $275 on the retail stock to rep 20% upside potential.</li> <li>Shares of Ulta are <font color='green'>up 1.47%</font> in premarket trading to $233.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320872\" data-linked=\"Wells Fargo sees &#39;compelling setup&#39; for Ulta Beauty\" data-tweet=\"$ULTA - Wells Fargo sees &#39;compelling setup&#39; for Ulta Beauty https://seekingalpha.com/news/3320872-wells-fargo-sees-compelling-setup-for-ulta-beauty?source=tweet\" data-url=\"https://seekingalpha.com/news/3320872-wells-fargo-sees-compelling-setup-for-ulta-beauty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320862\" data-ts=\"1514985716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMC\" target=\"_blank\">CMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320862-commercial-metalsplus-9-on-strong-fq1-beat-sunny-q2-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Commercial Metals +9% on strong FQ1 beat, sunny Q2 outlook</a></h4><ul>     <li>Commercial Metals (NYSE:<a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a>)&nbsp;<font color='green'>+8.9%</font> premarket after easily beating <a href=\"https://seekingalpha.com/news/3320816-commercial-metals-beats-0_13-beats-revenue\" target=\"_blank\">FQ1 earnings</a> expectations and topping year-ago quarterly revenues by 24%.</li>     <li>CMC says it typically sees lower shipment levels during its FQ2 due to winter weather conditions impairing construction activity, but \"end markets in both non-residential construction and original equipment  manufacturers are forecasting growth, and we are seeing that reflected in our shipment volumes.\"</li>     <li>Shares look to extend yesterday's 6.7% surge that followed CMC's plan to <a href=\"https://seekingalpha.com/news/3320566-commercial-metals-buy-u-s-rebar-assets-gerdau-600m\" target=\"_blank\">pay $600M to acquire</a> Gerdau's U.S. steel rebar assets, which analysts say could <a href=\"https://www.wsj.com/articles/commercial-metals-bolsters-holdings-of-a-construction-steel-1514921924\" target=\"_blank\">help reduce pricing pressure</a> on rebar, much of it coming from foreign steel companies.</li>     <li>Jefferies analysts say the move would raise CMC's share of rebar consumed in the U.S. to ~40% from 21%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320862\" data-linked=\"Commercial Metals +9% on strong FQ1 beat, sunny Q2 outlook\" data-tweet=\"$CMC - Commercial Metals +9% on strong FQ1 beat, sunny Q2 outlook https://seekingalpha.com/news/3320862-commercial-metalsplus-9-on-strong-fq1-beat-sunny-q2-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3320862-commercial-metalsplus-9-on-strong-fq1-beat-sunny-q2-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320858\" data-ts=\"1514985358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320858-ibm-called-attractive-large-cap-value-top-analyst-sharesplus-1_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM called &quot;attractive large-cap value&quot; by top analyst; shares +1.4%</a></h4><ul><li>        RBC Capital Markets <a href=\"https://www.cnbc.com/2018/01/03/ibm-shares-rise-after-rbc-upgrades-stock.html\" target=\"_blank\">upgrades</a> IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) from Sector Perform to Outperform and increases the price target by $20 to $180. &nbsp;</li><li>        Analyst Amit Daryanani writes, &ldquo;We think IBM is an attractive large-cap value stock for investors in 2018 as the potential for revenue and margin stability should enable a re-rating. A return to gross margin stability coupled with revenue growth in 2018 should set-up the stock for a year of outperformance especially considering the depressed valuation.&rdquo;</li><li>               IBM shares are&nbsp;<font color='green'>up 1.4%</font>&nbsp;premarket. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320510-2017-leaders-laggards\" target=\"_blank\">2017 leaders and laggards</a> (Dec. 31, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3320858\" data-linked=\"IBM called &quot;attractive large-cap value&quot; by top analyst; shares +1.4%\" data-tweet=\"$IBM - IBM called &quot;attractive large-cap value&quot; by top analyst; shares +1.4% https://seekingalpha.com/news/3320858-ibm-called-attractive-large-cap-value-top-analyst-sharesplus-1_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3320858-ibm-called-attractive-large-cap-value-top-analyst-sharesplus-1_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320847\" data-ts=\"1514984554\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACM\" target=\"_blank\">ACM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320847-aecom-fluor-upgraded-baird-in-positive-view-toward-e-and-c\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aecom, Fluor upgraded at Baird in positive view toward E&amp;C</a></h4><ul>     <li>Aecom Technology (NYSE:<a href='https://seekingalpha.com/symbol/ACM' title='AECOM Technology Corporation'>ACM</a>) <font color='green'>+2.1%</font> and Fluor (NYSE:<a href='https://seekingalpha.com/symbol/FLR' title='Fluor Corporation'>FLR</a>)&nbsp;<font color='green'>+1.3%</font> premarket after Baird <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Baird+Upgrades+AECOM+Technology+%28ACM%29+to+Outperform/13645554.html\" target=\"_blank\">upgrades</a> shares of the two companies to Outperform from Neutral, saying it is positively biased toward the engineering and construction sector as the industry enters 2018 with the best opportunity for net backlog and earnings growth in several years.</li><li>Baird believes the E&amp;C sector offers pockets of better relative risk/reward, particularly against signs of strengthening end markets and a bottom in commodity investment.</li><li>Previous problem projects and multi-year restructuring activities are now largely completed, the firm says, providing a cleaner basis for investors returning to the sector.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320847\" data-linked=\"Aecom, Fluor upgraded at Baird in positive view toward E&amp;C\" data-tweet=\"$ACM $ACM $FLR - Aecom, Fluor upgraded at Baird in positive view toward E&amp;C https://seekingalpha.com/news/3320847-aecom-fluor-upgraded-baird-in-positive-view-toward-e-and-c?source=tweet\" data-url=\"https://seekingalpha.com/news/3320847-aecom-fluor-upgraded-baird-in-positive-view-toward-e-and-c\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320846\" data-ts=\"1514984485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTN\" target=\"_blank\">PTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320846-palatin-to-start-clinical-development-of-uc-candidate-plminus-8177-shares-up-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palatin to start clinical development of UC candidate PL-8177; shares up 6% premarket</a></h4><ul><li>Palatin Technologies (NYSEMKT:<a href='https://seekingalpha.com/symbol/PTN' title='Palatin Technologies, Inc'>PTN</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket on average volume on the heels of its <a href=\"https://seekingalpha.com/pr/17036483-palatin-technologies-inc-announces-fda-clearance-investigational-new-drug-ind-application\" target=\"_blank\">announcement</a> that the FDA has signed off on its IND seeking approval to start clinical trials assessing PL-8177 for the treatment of ulcerative colitis &#40;UC&#41;.</li><li>A Phase 1 single and ascending dose study should start this quarter.</li><li><a href=\"https://www.palatin.com/research-focus/inflammatory-disease/\" target=\"_blank\">PL-8177</a> is a selective melanocortin receptor 1 (MC1r) agonist peptide. In other words, it is a modulator of the <a href=\"https://en.wikipedia.org/wiki/Central_melanocortin_system\" target=\"_blank\">melanocortin system</a> which plays a key role in appetite and energy expenditure.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320846\" data-linked=\"Palatin to start clinical development of UC candidate PL-8177; shares up 6% premarket\" data-tweet=\"$PTN - Palatin to start clinical development of UC candidate PL-8177; shares up 6% premarket https://seekingalpha.com/news/3320846-palatin-to-start-clinical-development-of-uc-candidate-plminus-8177-shares-up-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3320846-palatin-to-start-clinical-development-of-uc-candidate-plminus-8177-shares-up-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320849\" data-ts=\"1514984436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLSQF\" target=\"_blank\">PLSQF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320849-trading-firm-soars-20-cryptos-boost-profits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading firm soars 20% as cryptos boost profits</a></h4><ul><li>Israeli-based Plus500 (<a href='https://seekingalpha.com/symbol/PLSQF' title='Plus500 Ltd.'>OTC:PLSQF</a>) announced <a href=\"https://www.cnbc.com/2018/01/03/plus500-stock-spikes-after-it-says-cryptocurrency-boom-boosted-profits.html?__source=twitter%7Cmain\" target=\"_blank\">record quarterly revenues </a>in Q4 and the addition of 246K customers, in part thanks to its cryptocurrency offerings.</li><li>The company offers \"contracts for difference\" (essentially derivatives) on thousands of financial instruments, including cryptos.</li><li>Shares are&nbsp;<font color='green'>higher by 21%</font>&nbsp;in London action.</li><li>The news could be of interest to exchange operators like CME Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CME' title='CME Group Inc.'>CME</a>) and CBOE Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CBOE' title='CBOE Holdings'>CBOE</a>), as well as brokers like TD Ameritrade (NASDAQ:<a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a>), E*Trade (NASDAQ:<a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a>), and Interactive Brokers (IEX:<a href='https://seekingalpha.com/symbol/IBKR' title='Interactive Brokers Group, Inc.'>IBKR</a>) offering access to those exchanges' Bitcoin futures contracts. E*Trade is<font color='green'> higher by 2.4%</font>&nbsp;premarket as it expands its Bitcoin offering from just the CBOE to the CME as well.</li><li>Also taking note would be Gain Capital (NYSE:<a href='https://seekingalpha.com/symbol/GCAP' title='GAIN Capital Holdings, Inc.'>GCAP</a>), which is soon set to globally roll out its crypto trading platform. GCAP<font color='green'> +0.75%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320849\" data-linked=\"Trading firm soars 20% as cryptos boost profits\" data-tweet=\"$PLSQF $PLSQF $CME - Trading firm soars 20% as cryptos boost profits https://seekingalpha.com/news/3320849-trading-firm-soars-20-cryptos-boost-profits?source=tweet\" data-url=\"https://seekingalpha.com/news/3320849-trading-firm-soars-20-cryptos-boost-profits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320848\" data-ts=\"1514984214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITRI\" target=\"_blank\">ITRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320848-itron-sharesplus-3-after-analyst-initiation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Itron shares +3% after analyst initiation</a></h4><ul><li>        Raymond James <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=ITRI:NSQ\" target=\"_blank\">initiates</a> Itron (NASDAQ:<a href='https://seekingalpha.com/symbol/ITRI' title='Itron, Inc.'>ITRI</a>) with a Strong Buy rating.</li><li>               Latest analyst recommendations: 3 Buy, 2 Outperform, 6 Hold, and 1 Underperform.&nbsp;</li><li>               Median price target: $78.&nbsp;</li><li>               Itron shares are&nbsp;<font color='green'>up 3%</font>&nbsp;premarket to $71.35.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320848\" data-linked=\"Itron shares +3% after analyst initiation\" data-tweet=\"$ITRI - Itron shares +3% after analyst initiation https://seekingalpha.com/news/3320848-itron-sharesplus-3-after-analyst-initiation?source=tweet\" data-url=\"https://seekingalpha.com/news/3320848-itron-sharesplus-3-after-analyst-initiation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320845\" data-ts=\"1514984177\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGLT\" target=\"_blank\">EGLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320845-egalet-partners-orapharma-to-co-promote-sprix-nasal-spray\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Egalet partners with OraPharma to co-promote SPRIX nasal spray</a></h4><ul> <li>Egalet Corporation (<a href='https://seekingalpha.com/symbol/EGLT' title='Egalet Ltd.'>OTC:EGLT</a>) has&nbsp;<a href=\"https://seekingalpha.com/pr/17036361-egalet-partners-orapharma-co-promote-sprix-nasal-spray\" target=\"_blank\">partnered</a> with OraPharma, Inc., a division of Valeant Pharmaceuticals, to co-promote <a href=\"https://www.sprix.com/#about\" target=\"_blank\">SPRIX</a> (ketorolac tromethamine) Nasal Spray to dentists, dental specialists and oral surgeons across the U.S.</li>                    <li>OraPharma will begin promoting SPRIX in Q1 2018 as part of a two-year agreement. Financial terms are not disclosed. Egalet has terminated its agreement with Septodont.</li><li>SPRIX Nasal Spray is a nonsteroidal anti-inflammatory drug indicated for the short-term (up to five days in adults) management of moderate to moderately severe pain that requires analgesia at the opioid level.</li><li>Shares of Egalet are up&nbsp;<font color='green'>7%</font>&nbsp;premarket on robust volume.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3320845\" data-linked=\"Egalet partners with OraPharma to co-promote SPRIX nasal spray\" data-tweet=\"$EGLT $ZCOR - Egalet partners with OraPharma to co-promote SPRIX nasal spray https://seekingalpha.com/news/3320845-egalet-partners-orapharma-to-co-promote-sprix-nasal-spray?source=tweet\" data-url=\"https://seekingalpha.com/news/3320845-egalet-partners-orapharma-to-co-promote-sprix-nasal-spray\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320844\" data-ts=\"1514983623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320844-amdplus-6_7-on-intel-chip-flaw-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD +6.7% on Intel chip flaw report</a></h4><ul><li>        Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) and AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) shares moving after a report from <a href=\"https://www.theregister.co.uk/2018/01/02/intel_cpu_design_flaw/\" target=\"_blank\">The Register</a> alleging an Intel processor chip security flaw forced redesigns of Linux and Windows kernels.</li><li>               Linux programmers and Microsoft are working on a fix with Microsoft expected to release the Windows change through a Patch Tuesday.&nbsp;</li><li>                  Apple&rsquo;s 64-bit macOS will also need an update.   </li><li>               The fixes will throttle the performance of Intel products. The Register reports that the &ldquo;effects are still being benchmarked,&rdquo; but estimates a slow down of 5% to 30%.&nbsp; Newer Intel chips will fare better. &nbsp;&nbsp;</li><li>               Intel shares are&nbsp;<font color='red'>down 2%</font>&nbsp;premarket.&nbsp;</li><li>               AMD shares are<font color='green'>&nbsp;up 6.7%</font>&nbsp;premarket.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320844\" data-linked=\"AMD +6.7% on Intel chip flaw report\" data-tweet=\"$INTC $INTC $AMD - AMD +6.7% on Intel chip flaw report https://seekingalpha.com/news/3320844-amdplus-6_7-on-intel-chip-flaw-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3320844-amdplus-6_7-on-intel-chip-flaw-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>247&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320841\" data-ts=\"1514983434\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARDX\" target=\"_blank\">ARDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320841-ardelyx-completes-t3mpominus-3-safety-extension-study-of-tenapanor-for-ibs-c\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ardelyx completes T3MPO-3 safety extension study of Tenapanor for IBS-C</a></h4><ul><li>Ardelyx (NASDAQ:<a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx'>ARDX</a>) has <a href=\"https://seekingalpha.com/pr/17036378-ardelyx-successfully-completes-t3mpominus-3-safety-extension-study-tenapanor-ibs-c\" target=\"_blank\">successfully</a> completed the safety extension portion of its Phase 3 T3MPO program, which supports the registration of <a href=\"https://www.ardelyx.com/what-we-do/\" target=\"_blank\">tenapanor</a> for the treatment of patients with irritable bowel syndrome with constipation (IBS-C).</li><li>Results showed a mean tenapanor compliance rate of ~98% among the 240 patients treated. The overall discontinuation rate in the study was just 2.1%.</li>                   <li>The positive results from both the T3MPO-1 and T3MPO-2 studies, combined with the extensive safety data, support Ardelyx's plans to submit its first NDA to the FDA for this indication in H2 2018.</li> <li>Tenapanor is an oral, experimental medication. Tenapanor&nbsp;acts by inhibiting, or blocking, the NHE3 transporter in the gastrointestinal tract to reduce the absorption of dietary sodium, leading to increased sodium within the gut.</li><li>Shares are up&nbsp;<font color='green'>6%</font>&nbsp;premarket on light volume.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320841\" data-linked=\"Ardelyx completes T3MPO-3 safety extension study of Tenapanor for IBS-C\" data-tweet=\"$ARDX - Ardelyx completes T3MPO-3 safety extension study of Tenapanor for IBS-C https://seekingalpha.com/news/3320841-ardelyx-completes-t3mpominus-3-safety-extension-study-of-tenapanor-for-ibs-c?source=tweet\" data-url=\"https://seekingalpha.com/news/3320841-ardelyx-completes-t3mpominus-3-safety-extension-study-of-tenapanor-for-ibs-c\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320838\" data-ts=\"1514982825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOG\" target=\"_blank\">HOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320838-harley-davidson-on-watch-after-longbow-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harley-Davidson on watch after Longbow warning</a></h4><ul> <li>Shares of Harley-Davidson (NYSE:<a href='https://seekingalpha.com/symbol/HOG' title='Harley-Davidson, Inc.'>HOG</a>) are on watch in early trading after Longbow Research warns on Q4 shipments volume.</li> <li>The firm says motorcyle customers are opting for cheaper or used bikes in an ongoing trend that could be a \"substantial recovery headwind\" this year.</li> <li>Longbow lowers its rating on Harley to Underperform from Neutral and drops its price target to $43.</li><li>Sources: Marketbeat.com, Bloomberg</li> <li>HOG <font color='red'>-3.32%</font> premarket to $50.33.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320838\" data-linked=\"Harley-Davidson on watch after Longbow warning\" data-tweet=\"$HOG - Harley-Davidson on watch after Longbow warning https://seekingalpha.com/news/3320838-harley-davidson-on-watch-after-longbow-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3320838-harley-davidson-on-watch-after-longbow-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320836\" data-ts=\"1514982618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSHZF\" target=\"_blank\">PSHZF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320836-hughes-corp-down-3_3-ackman-lightens-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hughes Corp. down 3.3% as Ackman lightens up</a></h4><ul><li>Pershing Square Holdings (<a href='https://seekingalpha.com/symbol/PSHZF' title='Pershing Square Holdings Ltd.'>OTCPK:PSHZF</a>) and Pershing Square L.P. are<a href=\"https://seekingalpha.com/pr/17036133-pershing-square-holdings-ltd-announces-proposed-sale-howard-hughes-corporation-common-stock\" target=\"_blank\"> teaming to sell 2.5M shares</a> in Howard Hughes Corporation (NYSE:<a href='https://seekingalpha.com/symbol/HHC' title='The Howard Hughes Corporation'>HHC</a>).</li><li>The reason for the sale, says Pershing, is to help facilitate a tender by PSCM Acquisition and Ackman and team for Pershing Square Holdings' public shares.</li><li>After the share sale, Pershing Square Capital Management will be an owner of 5.1% of HHC common stock, and have another 12.5% economic interest in the company via total return swaps - a total interest of 17.6%.</li><li>Alongside, Hughes Corp. <a href=\"https://seekingalpha.com/pr/17036270-howard-hughes-corporation-announces-disposition-several-non-core-assets\" target=\"_blank\">announces the sale</a> of a number of non-core assets totaling about $90M.</li><li>HHC&nbsp;<font color='red'>-3.35%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3320836\" data-linked=\"Hughes Corp. down 3.3% as Ackman lightens up\" data-tweet=\"$PSHZF $PSHZF $HHC - Hughes Corp. down 3.3% as Ackman lightens up https://seekingalpha.com/news/3320836-hughes-corp-down-3_3-ackman-lightens-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3320836-hughes-corp-down-3_3-ackman-lightens-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320831\" data-ts=\"1514982456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320831-ambarellaplus-1_8-on-analyst-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ambarella +1.8% on analyst upgrade</a></h4><ul><li>        Oppenheimer <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=newssearch&amp;cd=1&amp;ved=0ahUKEwjDuYOI4rvYAhUH_IMKHXWuA20QqQIIJSgAMAA&amp;url=https%3A%2F%2Fwww.streetinsider.com%2FAnalyst%2BComments%2FOppenheimer%2BUpgrades%2BAmbarella%2B%28AMBA%29%2Bto%2BOutperform%3B%2BConcerns%2Bare%2BBehind%2BUs%2C%2BCV%2Bin%2BFocus%2F13645836.html&amp;usg=AOvVaw1J9kUi9xJleCFR26Z4sCIa\" target=\"_blank\">upgrades</a> Ambarella (NASDAQ:<a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a>) to Outperform from Perform with a $70 price target, which is 10% above the current share price.</li><li>               Latest analyst <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=AMBA:NSQ\" target=\"_blank\">recommendations</a>: 1 Buy, 2 Outperform, and 6 Hold.&nbsp;</li><li>               Median price target: $53.&nbsp;</li><li>               Ambarella shares are&nbsp;<font color='green'>up 1.8%</font>&nbsp;premarket to $63.45.&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320831\" data-linked=\"Ambarella +1.8% on analyst upgrade\" data-tweet=\"$AMBA - Ambarella +1.8% on analyst upgrade https://seekingalpha.com/news/3320831-ambarellaplus-1_8-on-analyst-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3320831-ambarellaplus-1_8-on-analyst-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320828\" data-ts=\"1514982069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/D\" target=\"_blank\">D</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320828-dominion-energy-scana-agree-to-all-stock-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dominion Energy, SCANA agree to all-stock merger</a></h4><ul>     <li>Dominion Energy (NYSE:<a href='https://seekingalpha.com/symbol/D' title='Dominion Energy, Inc.'>D</a>) and SCANA&nbsp;(NYSE:<a href='https://seekingalpha.com/symbol/SCG' title='SCANA Corporation'>SCG</a>) <a href=\"https://seekingalpha.com/pr/17036428-dominion-energy-scana-announce-stock-merger-1000-immediate-cash-payment-average-south\" target=\"_blank\">agree to merge</a> in an all-stock deal that would create a combined company serving 6.5M electric and natural gas distribution customers in eight states.</li>     <li>SCG shareholders would receive 0.669 Dominion common shares for each common share of SCG, the equivalent of $55.35/share; the transaction is valued at ~$14.6B, including assumption of debt.</li>     <li>The deal calls for benefits for customers of Scana's SCE&amp;G subsidiary to offset previous and future costs related to the withdrawal of operating licenses for the unfinished V.C. Summer nuclear reactors.</li><li>SCG&nbsp;<font color='green'>+21.5%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320828\" data-linked=\"Dominion Energy, SCANA agree to all-stock merger\" data-tweet=\"$D $D $SCG - Dominion Energy, SCANA agree to all-stock merger https://seekingalpha.com/news/3320828-dominion-energy-scana-agree-to-all-stock-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3320828-dominion-energy-scana-agree-to-all-stock-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>119&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320818\" data-ts=\"1514980311\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRSP\" target=\"_blank\">CRSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320818-crispr-therapeutics-readies-equity-offering-shares-down-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CRISPR Therapeutics readies equity offering; shares down 1% premarket</a></h4><ul><li>CRISPR Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a>) is off&nbsp;<font color='red'>1%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17036371-crispr-therapeutics-announces-proposed-public-offering-common-shares\" target=\"_blank\">announcement </a>of a $100M public offering of common stock. Price and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320818\" data-linked=\"CRISPR Therapeutics readies equity offering; shares down 1% premarket\" data-tweet=\"$CRSP - CRISPR Therapeutics readies equity offering; shares down 1% premarket https://seekingalpha.com/news/3320818-crispr-therapeutics-readies-equity-offering-shares-down-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3320818-crispr-therapeutics-readies-equity-offering-shares-down-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:51 AM </div></div></li>","count":72,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}